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Abstract 
 
Cortical interneurons are GABAergic inhibitory neurons localised in the cerebral cortex 
where they establish local connections and regulate the excitatory/inhibitory input onto 
cortical networks. Cortical interneuron dysfunction is thought to underlie the aetiology of 
neurodevelopmental disorders (NDDs), such as autism, schizophrenia and epilepsy.  
The ability of human pluripotent stem cells (hPSCs) to give rise to any cell type of the body 
make them a valuable tool to study cell fate specification. Moreover, they can provide an 
unlimited source of interneuron populations for diseases modelling, drug screening and 
regenerative medicine purposes. Nonetheless, such application can be greatly benefited by 
the generation of reporter cell lines that allow the identification of specific cell types, which 
in turn can facilitate the development of better differentiation protocols.  
This thesis reports the generation of a LHX6-mCherry/PV-GFP reporter cell line for tracking 
hPSC-derived cortical interneurons. The reporter cells can readily acquire medial ganglionic 
eminence (MGE)-like identity upon in vitro differentiation, with mCherry signal restricted 
to the MGE lineage and faithfully labels LHX6+ cells. These findings validate the potential of 
this reporter line as a useful tool for future investigations into potential MGE-fate 
determinants and interneuron subtype specification. However, the poor efficiency in 
generating parvalbumin+ neurons limited the functional verification of the PV-GFP reporter.  
 I then exploited the LHX6-mCherry reporter cells in an investigation of TGFβ signalling in 
cortical interneuron development. Pharmacological inhibition of this pathway keeps the 
MGE-like cells as progenitors through prolonging the cell cycle, while the addition of 
exogenous TGFβ3 accelerated mCherry+ cells production (postmitotic-cells).  These findings 
unravelled a novel function of TGFβ signalling in controlling the balance between MGE-like 
progenitor maintenance and neuronal differentiation.  
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1. Introduction  
 
 
1.1 Cortical interneurons and neurodevelopmental disorders 
1.1.1 Cortical interneuron diversity  
The neocortex is the brain region where the higher specialised functions are processed. 
It is assembled by cortical networks built up by cortical glutamatergic projection neurons 
(excitatory neurons, also known as pyramidal neurons), which transmit information 
from different regions of the neocortex and other brain regions. On the other hand, 
cortical interneurons possess axons that branch within the cortex, known as local 
projections, where they function to establish connections between different neuronal 
types to modulate network activity (Marin, 2012; Tremblay et al., 2016). Most cortical 
interneurons use GABA (Gamma-Aminobutyric Acid) as neurotransmitter, and hence, 
they are inhibitory neurons. 
The inhibitory function of cortical interneurons enables them to modulate the responses 
of pyramidal cells to input signals, preventing over-excitation of cortical circuitries and 
synchronising oscillatory activity (Tremblay et al., 2016). Although all of cortical 
interneurons release GABA, they are diverse in morphology, connectivity and 
electrophysiological properties as well as in the expression of cellular markers (Kelsom 
and Lu, 2013; Marin, 2012; Tremblay et al., 2016). All this diversity underlies differences 
in synaptic kinetics and intrinsic membrane properties,   which in turns results in a highly 
precise spatiotemporal control of the activity of local networks. 
 The expression of cellular markers have provided a good starting point to classify 
interneurons diversity, since three main interneuron types account for nearly the 
totality of GABAergic interneuron population in the mouse neocortex (Kelsom and Lu, 
2013; Tremblay et al., 2016). These interneurons types are: parvalbumin (PV+), 
somatostatin (SST+) and serotonin receptor (5HT3aR+) expressing interneurons.  From 
these three virtually non-overlapping interneurons populations, PV+ and SST+ represent 
around 70% of total interneurons (Wamsley and Fishell, 2017), while PV+ type 
constitutes 40% of the total GABAergic interneurons (Kelsom and Lu, 2013).  
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In addition to biochemical markers, interneurons are further classified in terms of their 
morphology. In case of   PV+ interneurons, two different morphologies can be 
distinguished: basket cells and chandelier cells, the former is characterised by targeting 
the soma and proximal dendrites of pyramidal neurons, while the later targets the initial 
axonal segment. SST+ are subdivide into Martinotti and non-Martinotti cells. The 
Martinotti cells are found through cortical layers II and VI being especially abundant in 
layer V. The non-Martinotti reside in all cortical layers.  Both of them target dendrites 
and function to facilitate excitatory inputs. A proportion of SST+ also expresses calretinin 
(CR+) (Kelsom and Lu, 2013).   
The 5HT3aR+ group is especially heterogeneous but the co-expression of other proteins 
of neuropeptides allows their classification into two main subgroups. One subgroup 
expressing the vasoactive intestinal peptide (VIP+) accounting for 40% of 5HT3aR+ cells, 
which is characterised for connecting onto dendrites, and largely co-express with CR. 
The remaining 60% of 5HT3aR+ interneurons is formed by a subgroup that does not 
express VIP and most of them express reelin+. Within this subgroup, neuroglial form 
interneurons are distinguished by their ability for making synapses with other 
interneurons from the same subtype as well as with other interneuron types (Kelsom 
and Lu, 2013; Wamsley and Fishell, 2017).  
The properties of the main interneuron classes including morphology, synaptic targets, 
distribution,   electrophysiological properties and expression of other markers, are 
summarised in Figure 1.1. All these properties account for the identification of 
interneuron subtypes, which emerge from transient embryonic regions known as 
ganglionic eminences in the developing ventral telencephalon (Hansen et al., 2013; 
Lavdas et al., 1999; Ma et al., 2013). PV and SST subtypes represent between the 5 to 
7% of total neurons in rodents and are derived from the medial ganglionic eminence 
(MGE), whereas CR+ proportion is three times increased in primates (12 % of total 
neuronal population) with respect to rodents (4%), and it is largely derived from the 
caudal ganglionic eminence (CGE), with the exception of those CR+/SST+ which are 
thought to be  generated within the MGE (Hladnik et al., 2014).  
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Figure 1.1| Classification of the main classes of cortical interneurons. The first level of 
classification is by expression of key biochemical markers, which divide cortical interneurons 
into three virtually non-overlapping populations. These are PV+, SST+ and 5HT3aR+ (comprising 
VIP+ and Reelin+ interneurons) which account for nearly the total number of interneurons. These 
main interneuron types are further divided into subgroups based on their morphology. These 
sub-classes show defined properties in terms of their synaptic targets and electrophysiological 
properties. From Wamsley and Fishell, 2017 
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1.1.2 Cortical interneuron dysfunction in neurodevelopmental disorders  
The abundance and function of cortical interneurons seems to be affected in 
neurodevelopmental disorders such as autism spectrum disorders, schizophrenia and 
epilepsy (Del Pino et al., 2013; Filice et al., 2016; Tremblay et al., 2016). For instance, 
mouse models deficient in genes implicated in cortical interneuron development, such 
as Sox6  displays reduction of SST+ and PV+ interneurons, defects in their laminar 
localisation and epileptic phenotypes (Batista-Brito et al., 2009) whereas a PV-null 
mouse recapitulates symptoms of autism spectrum disorders (ASD) in humans such as 
decreased social interaction, stereotyped behaviours and impairment in communication 
(Wohr et al., 2015). Another line of evidence comes from the studies of mutant mouse 
models of the SHANK gene family, which codes for scaffolding proteins located in the 
post-synaptic density of glutamatergic synapses. Mutations in this gene-family have 
been often found in individuals with schizophrenia and ASD, and decreased expression 
of PV has been found in Shank1 and Shank3 null mice that display ASD phenotype (Filice 
et al., 2016) .  
Additionally deletion of Erbb4 (a gene expressed in migrating cortical interneurons) in 
PV+ interneurons resulted in a schizophrenia-like phenotype (Del Pino et al., 2013). 
These observations, along with interneuron function to dynamically modulate network 
activity, have suggested a correlation between interneuron dysfunction and clinical 
features of neurodevelopmental disorders; hence, it has been proposed that severe 
defects in the function of inhibitory interneurons might cause an instability of cortical 
networks, which leads to an excitatory/inhibitory impairment. Figure 1.2 illustrates 
some of defects founds in cortical networks in patients or mouse models of 
schizophrenia.   Many more investigations have related interneuron dysfunction or gene 
mutations related to interneuron development with neurodevelopmental disorders, 
which has been summarised by Marin, 2012.  
Therefore, the establishment of differentiation protocols to obtain human MGE 
interneurons in vitro hold an enormous potential to study not only the specific 
mechanisms of  interneuron development in humans, but also to serve for modelling 
neurodevelopmental diseases. Although this research is focused in the study of MGE-
derived interneurons due to evidences linking them to neurodevelopmental diseases, 
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the larger proportion of CGE-derived interneurons found in primates, is suggestive of a 
possible relevance of CR+ population, which also should be considered in future studies.   
 
 
 
 
Figure 1.2|    Impairments in cortical networks found in patients and animal models of 
schizophrenia. a) A reduction in GAD67 expression in PV interneurons is often found in this 
disorder. This reduction may lead to compensatory mechanisms such a reduced mRNA 
expression of GAT1, which encodes a transporter responsible for re-uptaking GABA at synapses. 
Other compensatory mechanisms could be an increase of GABA receptors onto pyramidal cells 
as well as a reduced number of spines. b) Interneuron dysfunction in schizophrenia have been 
related to cell-autonomous impairments in interneuron sub-types, named the presynaptic 
mechanism or a post-synaptic mechanisms explained by reduction of excitatory inputs to PV+ 
interneurons along with a loss of inhibitory  drive  from PV to pyramidal cells as has been 
observed in  a conditional mutation of Erbb4. Therefore, it is hypothesised that pyramidal cells 
might be hyperactive and asynchronous in the cortex of schizophrenia-patients. From Marin, 
2012.  
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1.2 Forebrain Development  
1.2.1 Emergence of the MGE in the ventral telencephalon 
As result of gastrulation in the mammalian embryo, three germ layers are developed: 
endoderm, mesoderm and ectoderm. From studies in frogs and fish, it has been 
proposed that ectodermal cells acquire neural identity unless they are exposed to bone 
morphogenetic proteins (BMP) signalling (Vieira et al., 2010). However, studies in other 
species suggests that in addition to BMP inhibition, an early signalling of fibroblast 
growth factor (FGF) is required for the induction of neural fate (Streit et al., 2000; Vieira 
et al., 2010). After the neural fate is acquired, local signalling leads to the establishment 
of cell populations known as organizers. This organizers secret morphogens and/or 
growth factors to orchestrate regional patterning,  which leads to the establishment of 
the anterior/posterior and dorsal/ventral axes in the embryonic neural tube (Vieira et 
al., 2010).  
From the anterior neuroectoderm develops the forebrain or prosencephalon, the 
embryonic region that gives rise to the telencephalon, where the expression of Foxg1 is 
initiated around E8.5 (Hebert and Fishell, 2008) by the effect of a group of cells called 
the anterior neural ridge (ANR), which promotes telencephalic gene expression. The 
ANR carries out its function by expressing inhibitors of WNT along with active FGF8 and 
sonic hedgehog (SHH) signalling (Vieira et al., 2010; Wilson and Houart, 2004). As a result 
of the concerted action of these signalling pathways, transient embryonic structures, 
named ganglionic eminences are developed at E11.5 in the ventral part of the embryonic 
telencephalon. These ganglionic eminences are the source of GABAergic interneurons. 
 
 
1.2.2 Medial ganglionic eminence: the major source of cortical 
interneurons   
The ganglionic eminences are named depending on their localization along the rostral-
caudal and dorsal-ventral axes of the subpallium: the medial ganglionic eminence (MGE) 
located in the rostral-ventral subpallium, the lateral ganglionic eminence (LGE) located 
in the rostral-dorsal and the caudal ganglionic eminence (CGE) in the most caudal region 
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of the subpallium (Danjo et al., 2011; Kelsom and Lu, 2013).  The MGE is the embryonic 
structure from which the vast majority of PV+ and SST+ cortical interneurons arise 
(Corbin and Butt, 2011; Kelsom and Lu, 2013; Lavdas et al., 1999). Newborn interneurons 
migrate tangentially from the MGE to populate the cortex (Lavdas et al., 1999). This 
configuration of three ganglionic eminences, and tangential migration of MGE-derived 
newborn interneurons towards the cortex is conserved in human developing forebrain 
(Hansen et al., 2013; Ma et al., 2013).  Studies in the mouse MGE revealed that Shh 
signalling promotes the expression of Nkx2.1 (Xu et al., 2005), a key transcription factor 
required to maintain regional identity in the MGE (Sussel et al., 1999) and for the 
specification of SST and PV cortical interneurons. Primary cultures from the cortex of the 
Nkx2.1-mouse knockout have no PV or SST interneurons (Xu et al., 2004).  
 Although a role of Nkx2.1 in promoting and maintaining MGE identity was stablished in 
1999, a genome-wide analysis of the transcription networks controlled by Nkx2.1 was 
only reported in 2016. This study revealed that Nkx2.1 acts as a repressor to prevent the 
expression of CGE and LGE genes. However, the combinatorial activity of Nkx2.1 and 
Lhx6 activates gene expression in the sub-ventricular zone and mantle zone in the 
developing MGE. These results suggested that these two transcription factors together 
control gene expression in the developing MGE (Sandberg et al., 2016).  
Since the expression of Lhx6 was first documented in the MGE, its role in cortical 
interneuron development has been extensively studied (Grigoriou et al., 1998; Lavdas 
et al., 1999). From these studies is known that Lhx6 is a direct target of Nkx2.1, and can 
rescue the lack of PV+ and SST+ neurons in Nkx2.1 null mice (Du et al., 2008). Additionally 
and in line with the proposed cooperative action of Nkx2.1 and Lhx6, the latter is also 
required for the specification and migration of SST+ and PV+ interneurons (Liodis et al., 
2007; Vogt et al., 2014). 
Downstream of Nkx2.1 and Lhx6, other transcription factors and genes such as Dlx5/6,  
Sox6, Arx, CXCR7, SATB1, Sp9 have been demonstrated to have a role in the 
development of  MGE-derived cortical interneurons (Kelsom and Lu, 2013; Liu et al., 
2019; Vogt et al., 2014). For instance, Dlx5/6 mutant mice have defects in the tangential 
migration of cortical interneurons and a 3-fold reduction in the number of PV+ 
interneurons (Wang et al., 2010), while Sox6 null mice display decreased numbers of PV+ 
and SST+ interneurons, defects in laminar localisation and epileptic phenotype (Batista-
8 
 
Brito et al., 2009).   Human MGE is also characterised by NKX2.1 and SOX6 expression. 
Although Nkx2.1 is necessary for the establishment of the MGE, it must be 
downregulated in progenitors fated to become cortical interneurons (Nobrega-Pereira 
et al., 2008). Human PV+, CB+, SST+, nNOS+ and NPY+ interneurons co-express SOX6, 
suggesting that they are derived from human MGE (Ma et al., 2013). Figure 1.3 depicts 
gene networks controlling the development of MGE-derived lineages.  
Recent findings from single cell RNA-seq have demonstrated the existence of highly 
heterogeneity of progenitors within the MGE. Such heterogeneity is thought to 
contribute explaining the diversity of interneuron subtypes developed from the MGE. In 
addition, these studies also allowed the identification of cell populations that 
prospectively would develop as SST+ or PV+ interneurons. Such molecular distinction 
could be found as early as 12.5 and 13.5 (Mayer et al., 2018; Mi et al., 2018). Therefore, 
it has been suggested that cell type-specific genetic programs might be established by 
the time interneurons become post-mitotic, however through migration and allocation 
to a laminar position, these cells will be exposed to different environments that allow 
the unfolding transcriptional programs to shape the final features of interneurons (Lim 
et al., 2018).  
 
 
Figure 1.3| Genes involved at different states of interneuron development.  Dlx genes have been 
shown to be necessary for GABAergic fate specification and repression of glial fate. Nkx2.1 
instructs and maintains the MGE identity by repressing the expression of CGE and LGE genes. 
Nkx2.1 transcriptionally activates Lhx6, together they promote a transcriptionally permissive 
chromatin to transcriptionally activate downstream genes involved in the migration and 
acquisition of mature features of PV+ and SST+ interneuron. Recently, it has been suggested that 
soon after cell cycle exit, a distinctive set of genes can be identified in cell populations that will 
later develop into PV or SST interneurons. From these candidate genes Mef2c and Maf had been 
validated for having a role in PV and SST specification. 
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1.2.3 Emergence of interneuron diversity from the MGE 
From the MGE emerges diversity of PV+ and SST+ interneurons. Such diversity is 
determined by the position of the progenitors within the MGE as well as by the time at 
which an interneuron is born (Hu et al., 2017b; Lim et al., 2018). For instance, it has been 
shown that the MGE can be subdivided into dorsal, intermediate and ventrocaudal 
domains, where the first two domains are specialised to give rise to cortical interneurons 
whereas the ventrocaudal domain produces PV+ projection neurons destined to the 
globus pallidus (Lim et al., 2018). Moreover, several lines of evidences suggested that 
progenitors from the caudal MGE have a tendency to differentiate as SST+ interneurons, 
whereas the rostral MGE-progenitors preferentially differentiate as PV+ interneurons. 
The bias on interneuron fate is dependent on the expression of Coup-TF2 in the caudal 
MGE that binds the putative Sox6 enhancer. Sox6 transcriptional activation controls the 
ratio of SST+ and PV+ interneurons generated by the caudal MGE (Hu et al., 2017a).  A 
bias for generating SST+ and PV+ interneurons has also been shown along the dorsal-
ventral axis of the MGE, where SST+ interneurons are preferentially generated by the 
dorsal MGE while PV+ are generated by progenitors in the ventral MGE (Wonders et al., 
2008). 
Paradoxically, even though there is a bias for the generation of distinct class of 
interneurons, the dorsal MGE still produces PV+ interneurons and vice versa. Moreover, 
the existence of a tendency to generate either fate at certain time in neurogenesis 
suggest that interneuron fate is guided not only by progenitor localization but also by 
the time of interneuron birth (Inan et al., 2012; Lim et al., 2018). Therefore, model of 
interneuron generation should take into account both spatial and temporal control of 
interneuron fate.  
A model proposed by Oscar Marin’s laboratory is based on the theory that MGE 
progenitors progress through intrinsic changes in their competence to produce MGE-
derived lineages. In this model, molecular specification of progenitors occurs in the 
ventricular zone of the MGE, where progenitors are assigned a probability to generate 
certain number of neurons at sequential competence states. Consequently, the 
capability of MGE-progenitors to sequentially generate projection neurons, SST+ and PV+ 
interneurons is biased. This model is illustrated in Figure 1.4, and it is consistent with 
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the reported works showing that molecularly distinct progenitor cells are present in the 
developing MGE.  In previous works, the heterogeneity within the MGE was interpreted 
as sub-regional specification of the MGE rather than a result of changes in the capability 
of progenitors to generate different kind of neurons at different competent states.  
However, this model predicts the existence of a transcription factor network, which 
would control the progression from one competent state to another. Recently Coup-TF2 
has been related to the control of SST and PV ratio in a time-dependent manner (Hu et 
al., 2017a), but more investigation remains to be done in order to find other 
transcription factors that regulates interneuron fate specification temporally.   
Recently, interneuron diversity in terms of biochemistry markers, morphology, 
connectivity and physiological properties have been explained by the implementation 
of specific transcriptional programs, that can be either intrinsic to cell populations or 
driven by the interaction with environment. These programs, named transcriptional 
modules are proposed to control each of the characteristics that contribute to 
interneuron diversity. Hence, interneuron diversity is conceived as the result of the 
combinatorial assembly of different transcriptional modules through development (Lim 
et al., 2018). This concept might explain how interneuron subtypes can share certain 
characteristics, like biochemistry markers, while being different in morphology or 
connectivity.  
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Figure 1.4| Integrated spatiotemporal model for neurogenesis in the MGE. This model considers 
a differential expression of transcription factors controlling the spatial patterning of the MGE 
into three different domains: dorsal MGE, intermediate MGE and caudo-ventral MGE. Secondly, 
these domains generate different numbers of neurons in a temporal sequence, where projection 
neurons are generated first, followed by SST interneurons and PV interneurons later on. Finally, 
interneurons are generated within each domain through progressive intrinsic changes in their 
competence to differentiate as a specific class of neuron. Where the generation of different 
numbers of each class of neuron is determined by the probability to generate these neurons at 
each competence state. From Lim, et al., 2018. 
 
 
 
 
 
 
1.2.4 Key signalling pathways directing MGE development  
As described in section 1.2.1, once telencephalic primordium was specified, signalling 
pathways and their associated effectors are implicated in the patterning and 
neurogenesis of the telencephalon. Below brief reviews of the mechanisms of these 
signalling pathways are presented. Recently activity of TGFβ signalling has been 
documented in the sub-pallium (Maira et al., 2010). Specifically TGFβ3 is expressed in 
the ventricular and sub-ventricular zone of the MGE, where its expression seems to be 
controlled by Nkx2.1 and Lhx6 (Sandberg et al., 2016).  
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1.2.4.1 Sonic Hedgehog signalling 
The establishment of the dorsal-ventral fate in telenchephalon is determined by the 
expression of Shh and Gli3 (glioblastoma proteins). Gli3 is broadly expressed in the 
telencephalic anlagen and is downregulated in the ventral portion, the disruption of Gli3 
expression impairs the development of the dorsal telencephalon. In contrast, Shh is 
expressed in the ventral neural plate and its expression is preserved along the ventral 
midline of the developing central nervous system. In the ventral telencephalon, Shh 
restricts the dorsalising effects of Gli3 (Hebert and Fishell, 2008). Shh is one of the three 
vertebrate hedgehog genes (Indian, Desert and Sonic), homologous to  one of the 
Drosophila segment polarity genes, the Hedgehog gene (Nusslein-Volhard and 
Wieschaus, 1980) and belongs to a family of  secreted glycoproteins. Shh has been 
widely reported to act as a morphogen, inducing different cell fates depending on the 
concentration of Shh to which cells are exposed.   
Shh is secreted as a precursor protein of approximately 45 kDa, which undergoes an 
autocatalytic cleavage that renders (approximately) a 20 kDa amino-terminal domain 
and a 25 kDa carboxylic terminal domain.  The amino terminal domain is responsible for 
the known biological activity whereas the carboxylic domain is necessary for the 
precursor processing acting as an intramolecular cholesterol transferase, which 
produces a lipid-modified-amino-terminal fragment that acts as an active Shh, and such 
modification seems to be necessary for the restriction of the localisation of Shh in tissues 
(Porter et al., 1996b). After cholesterol addition to the N-terminal, a palmitoyl residue is 
additionally added by the acyl- transferase Ski (Porter et al., 1996a). 
Cells expressing the transmembrane receptor Patched1 (Ptc1) are able to respond to                                                          
Shh. In the absence of Shh, Ptc1 inhibits the activity of the co-receptor Smoothened 
(Smo). Binding of Shh to Ptc1 relieves this repression. Activated Smo initiate 
downstream signalling which leads to the activation of Gli transcription factors 
(Choudhry et al., 2014). Three Gli proteins are found in vertebrates, Gli1 and Gli2 have 
activator functions, while Gli2 and Gli3 can undergo proteolysis to produce repressor 
forms (Choudhry et al., 2014; Ruiz i Altaba et al., 2002). Finally, Gli proteins exert their 
action on Shh-target genes as transcriptional activators or repressors.  In the context of 
the MGE, Shh activity is necessary for the expression of Nkx2.1 (Xu et al., 2005), 
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therefore in this thesis recombinant Shh and purmorphamine (PM), a Smo agoinst (Sinha 
and Chen, 2006), were employed for the in vitro derivation of MGE-like cells.  
 
 
1.2.4.2 WNT signalling  
Wnt signalling and its relevance in anterior patterning is well demonstrated by a Tcf3 (T-
cell factor 3) mutant zebrafish, which lacks eyes, forebrain and part of the midbrain. It 
was shown that Tcf3 function as a repressor of Wnt signalling is critical for head 
formation (Kim et al., 2000). Additionally, Wnt/β-catenin signalling participates in the 
establishment in the dorsoventral axis in the telencephalon, which is activated in the 
telencephalic roof and constitutes a Shh-independent pathway controlling pallial 
specification. Foxg1 is a central player in the coordination of Shh and Wnt signalling 
activities. Foxg1 is an effector of Shh and inhibits Wnt signalling in the sub-pallium by 
direct transcriptional repression of Wnt8b; as a result pallial identities are excluded from 
the ventral telencephalon (Danesin et al., 2009). 
The human genome contains 19 WNT cysteine rich glycoproteins proteins that are 
around 40 kDa of size and are post-translationally modified by glycosylation and 
palmitoylation. Wnt ligands are secreted through interaction with the GPR177 protein 
and transduce their signal through a heterodimer receptor formed by a protein of the 
Frizzled (FZD) family and LRP5 or LPR6 (lipoprotein receptor-related protein).  Binding of 
the Wnt ligands to the FZD-LPR5/6 receptor recruits Dishevelled and Axin-GSK3 
(glycogen synthase kinase 3) –APC (Adenomatous polyposis coli protein) complex.  The 
recruitment of this complex to Wnt receptors inhibits β-catenin phosphorylation and 
prevents its degradation. These events leads to a subsequent accumulation of β-catenin, 
which is translocated to the nucleus to exert its action as a transcriptional co-activator 
by binding Tcf/lef (T-cell factor/lymphoid enhancing factor). In absence of β-catenin 
nuclear accumulation, Tcf/lef repress Wnt targets by interacting with Groucho/Tle 
(transducin-like enhancer protein) co-repressors (Steinhart and Angers, 2018; 
Yamaguchi, 2001).  
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Several mechanisms are known to restrict Wnt signalling in the embryonic regions 
where it should be suppressed as in the case of anterior/ventral telencephalon. For 
instance, Wnt ligands can be inhibited by direct interaction with Wnt inhibitory factors 
(WIF), which prevent their association with the receptor complex. A similar mechanisms 
is shared by the secreted frizzled related proteins (sFRPs). Other class of inhibitors are 
the Dickkopf (DKK) proteins, which act as competitive inhibitors by binding to the LRP5/6 
receptors. An additional inhibitory mechanism is via negative feedback by axin proteins. 
Axin2 (a Wnt target gene) is the limiting component of the β-catenin destruction 
complex. Therefore, increased activity of Wnt signalling enhance Axin2 transcriptional 
activation, which rises the availability of the β-catenin destruction complex and β-
catenin degradation (Huang et al., 2009; Steinhart and Angers, 2018). Specifically, this 
mode of Wnt signalling inhibition was exploited in the differentiation paradigm 
employed in this thesis, where the XAV939 inhibitor was added during the neutralisation 
of hPSCs. This inhibitor acts through the inhibition of poly-ADP-ribosylating enzymes 
tankyrase1 and tankyrase2. These enzymes promotes Axin degradation by the ubiquitin-
proteasome system. Hence, the inhibition of tankyrases stabilises Axin and increases β-
catenin degradation (Huang et al., 2009). In this thesis, XAV939 was chosen because it 
has been shown that the proportion of FOXG1+ cells generated by XAV939 addition was 
larger than the generated by recombinant DKK1. Moreover the effect if XAV939 was 
consistent across multiple hESCs  and iPSCs(Maroof et al., 2013). 
 
 
1.2.4.3 TGFβ signalling in MGE development 
1.2.4.3.1 Involvement  of TGFβ in neural development  
Throughout the central nervous system development, TGFβ family has been 
documented to regulate several steps of neurodevelopment, starting by the 
establishment of the neural plate, which is allowed by the inhibition of TGFβ family 
members, such as BMPs and nodal. Afterwards members of TGFβ superfamily have also 
been implicated in neural tube patterning, neuronal migration and synaptogenesis 
(Extensively reviewed by Meyers and Kessler, 2017). In the context of patterning, 
members of TGFβ family, along with Wnts and Shh, orchestrate the formation of 
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ventral/dorsal axis in the neural tube (Choudhry et al., 2014; Meyers and Kessler, 2017; 
Yamaguchi, 2001). BMPs are inducers of the roof plate stablishing the dorsal identity, 
where Wnt activity is also displayed (Danesin et al., 2009),  whereas the activity of Shh, 
potentiated by Nodal, instruct the establishment of the floor plate and with it, the 
ventral identity (Meyers and Kessler, 2017). 
At the stage of neuronal specification in the forebrain, TGFβ superfamily members, 
specifically BMP4 signalling has been reported to have a role in the acquisition of PV 
interneuron fate in mouse. Primary cultures of interneuron precursors from the MGE, 
treated with BMP4 displayed an accelerated maturation and acquisition of PV fate at 
the expenses of SST+ interneurons (Mukhopadhyay et al., 2009). The authors proposed 
that BMP4 does not have a role in primary GABAergic fate specification, however it has 
differential effects on terminal differentiation of PV+ and SST+ interneurons in GABAergic 
precursors already specified by SHH. Their results suggested that interneurons 
precursors derived from the MGE expressing BMPR1a receptors respond to high levels 
of cortical BMP4 during their migrating towards the cortex, promoting PV+ interneuron 
differentiation while reducing the number of a subset of SST+ interneurons. 
(Mukhopadhyay et al., 2009).  
With respect to migration and axonal guidance, TβRI (transforming growth factor beta 
receptor 1) has been reported to be expressed in the developing and postnatal mouse 
cortex along radial glial fibres. Moreover TFGβ1 signalling has been implicated in the 
regulation of neural cell-adhesion molecules, such as N-CAM and integrins sub-units 
(Meyers and Kessler, 2017). TGFβ superfamily has been related to the control of the 
migration of sub-pallial derivatives towards the cortex. In an ex-vivo approach the 
expression of dominant negative SMAD4 (a mediator of TGFβ signalling) impaired cell 
migration from the subpallium towards the cortex (Maira et al., 2010).  This effect on 
migration was suggested to be in control of redundant function of the BMP/GDF (growth 
and differentiation factor) and the TGFβ/Activin/Nodal branches of the TGFβ 
superfamily. 
TGFβ signalling has also been shown to interact with transcription factors important for 
murine MGE development. Specifically, TGFβ3 is proposed to be a component of the 
transcriptional network regulated by Nkx2.1. Since TGFβ superfamily has been 
documented to control several stages of neural development, and that the putative 
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enhancer of TGFβ3 is preferentially active in the SVZ of the developing MGE where can 
be regulated by Nkx2.1 and Lhx6, it is possible that TFGβ3 might control other aspects 
than migration of MGE development.  
 
 
1.2.4.3.2 An overview of TGFβ signalling  
The TGFβ superfamily proteins comprises over 30 members in humans,  TGFβ signalling 
transduction starts when the ligand binds to their receptors, which are Ser/Thr protein 
kinases: Type I and type II receptors (TβRI and  TβRII). Ligand/receptor binding allows 
TβRII to phosphorylate TβRI in its GS (Glycine-Serine kinase domain), which is a 
characteristic feature of TβRI but not present in TβRII. The phosphorylation of TβRI leads 
to a change in its affinity to bind the inhibitor FKBP12. The change in affinity activates 
TβRI and creates a binding site in its GS domain for the receptor regulated Smad-
proteins (R-Smads:  Smad 1,2,3,5 and 8) (Huse et al., 2001). The access of the activated 
receptor complex to R-Smads is enhanced by SARA (Smad anchor for receptor 
activation) proteins, which immobilise Smad2 and Smad3 close to the cell membrane.   
The phosphorytated R-Smad then dimerizes with the co-mediator Smad (Co-Smad: 
Smad4) and translocated to the nucleus, where along with others co-activators or co-
repressors transcriptionally regulate TGFβ-target genes. A third class of Smad proteins, 
known as inhibitory Smads (I-Smads: Smad6 and Smad7) function to negatively regulate 
TGFβ signalling through a variety of mechanisms such as, competing for receptors, 
inducing receptors degradation and competing for interaction with Co-Smad (Shi and 
Massague, 2003).  Further regulation of TGFβ signalling occurs by the action of proteins 
regulating the access of the ligands to their receptors, such proteins are generally known 
as ligand traps (Massague, 2012; Shi and Massague, 2003).  
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Figure 1.5| Diagram of TGFβ signalling.  TGFβ binds the TβRII receptor which in turns 
phosphorylates the TβRI in its GS domain, creating a change in the affinity of TβRI to 
bind inhibitor FKBP12, leading to the recruitment and phosphorylation of R-Smads. 
Active R-smads dimerizes with co-Smads and together are translocated to the nucleus 
where they can interact with co-activator or co-represors to mediate transcriptional 
regulation on TGFβ targets.  From Shi, 2003 
 
 
The TGFβ superfamily is divided into two branches or subfamilies, the 
TGFβ/Activin/Nodal subfamily and the BMP/GDF/MIS (Mullerian inhibiting substance) 
subfamily (Massague, 2012; Shi and Massague, 2003). In spite of the variety of TGFβ 
ligands, they share common features in their primary and tertiary structure. Briefly, an 
active TGFβ ligand is a dimer formed by disulphide bridges and stabilised by hydrophobic 
interactions.  It displays specificity to bind to a certain combination of the seven type I 
receptors and five type II receptors existing in humans (Massague, 2012; Shi and 
Massague, 2003).  Table 1.1 shows the combination of receptors that different members 
of TGFβ superfamily binds, the R-Smads that each member phosphorylates and the 
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Traps proteins that regulates them.   All the combinations through which TGFβ 
superfamily transduces signals enable it to display a plethora of, sometimes opposite, 
effects; which are highly context dependent, as extensively explained in Massague, 
2012.  
 
Table 1.1| Classification of TGFβ superfamily ligands, receptors and inhibitors.   
 
 
 
 
1.3 Human pluripotent stem cells as model to investigate cortical 
interneuron development 
hPSCs includes the human embryonic stem cells (hESCs) and the induced Pluripotent 
Stem Cells (iPSCs). These cells are characterised by their potential to give raise to any 
cell type in the body and unlimited self-renewal capability. hESCs are  derived from the 
inner cell mass of the human developing embryo at the blastocyst stage, while iPSCs are 
induced  in vitro  by forced expression of the transcription factors OCT4, SOX2, KLF4, and 
C-MYC, whose combined expression is highly specific to the pluripotent state (Takahashi 
Family 
member  
Receptor I  Receptor II R-Smad Traps 
TGFβ TβRI (ALK5)  TβRII Smad2/Smad3 LAP,  Decorin 
Activin ACVR1 (ALK2), 
ACVR1B (ALK4), 
ACVR1C (ALK7) 
ACVR2A, 
ACVR2B 
Smad2/Smad3 Follistatin 
Nodal ACVR1 (ALK2), 
ACVR1B (ALK4), 
ACVR1C (ALK7 
ACVR2A, 
ACVR2B 
Smad2/Smad3 Cerberus 
BMP BMPR1A (ALK3) 
BMPR1B (ALK7) 
ACVR2A, 
ACVR2B 
Smad1/Smad5
/Smad8 
Cerberus, Chordin, 
Follistatin, Noggin 
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and Yamanaka, 2006). In this thesis the term hPSCs is used to refer to hESCs, which can 
be identified by expressing specific cell surface markers such as stage-specific embryonic 
antigen (SSEA-3 and SSEA-4) (Thomson et al., 1998), as well as by the expression of 
pluripotency-related transcription factors: OCT4, NANOG, SOX2 among others 
(Brandenberger et al., 2004).  Due to their differentiation potential, they have been used 
as an in vitro model of somatic cell differentiation (Reubinoff et al., 2000) for analysing 
several steps of commitment towards a particular cell fate (Murry and Keller, 2008). 
The culture system for maintaining hPSCs has evolved over the years, moving from the 
use of mitotically inactivated mouse or human embryonic fibroblasts as feeder cells and 
chemically undefined media to feeder-free and chemically defined media. These 
changes led to an increases in experimental reproducibility as well as making hPSC works 
relatively less labour intensive (Dakhore et al., 2018).  Extensive research has been done 
in understanding the mechanisms that govern pluripotency of hPSCs, which helped the 
development of improved culture media and substrates for maintaining hPSCs. Most of 
the currently available media contains bFGF, TGFβ, insulin and transferrin.  bFGF was 
one of the first growth factor identified  to be indispensable for pluripotency and self-
renewal of hESCs. This factor was found to be released to the media from hPSCs, 
suggesting the presence of an autocrine signalling. The inhibition of this autocrine 
signalling by pharmacological inhibition of FGF receptor using SU5402 resulted in cell 
differentiation (Dvorak et al., 2005) 
The TGFβ/activin/Nodal branch of the TGFβ superfamily, which signals through the 
activation of SMAD2/3 transducer, was also shown to be activated in hPSCs self-renewal 
condition.  Upon early differentiation, SMAD2/3 activity was decreased.  This pathway 
is required for the maintenance of pluripotency-related-markers and was also required 
downstream of WNT signalling activation for the maintenance of PSCs in an 
undifferentiated state (James et al., 2005).  
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1.3.1 Directed differentiation of hPSCs to cortical interneurons  
1.3.1.1 Neural induction  of hPSCs 
Knowledge gained from developmental biology allowed understanding of basic 
mechanisms guiding embryonic development towards neural fate. This knowledge has 
been applied to stem cell research for in vitro derivation of cell lineages of interest. 
Initially, differentiation of stem cells was carried out via the formation of three-
dimensional structures called embryoid bodies, which mimic a developing embryo 
where the three germ layers are form. However, this approach has a major drawback 
due to  the variability between embryoid bodies and experiments (Tao and Zhang, 2016). 
During embryonic development, neural induction from the ectoderm requires the 
inhibition of SMAD signalling, as BMP inhibitors such as chordin, follistatin and noggin 
are known neural-inducing factors in vertebrates (Pera et al., 2014). This knowledge was 
applied in designing improved neural induction protocols for hPSCs. Following the initial 
finding that Noggin can efficiently induce neural fate conversion of hESCs (Gerrard et al., 
2005), Chambers and colleagues developed a more efficient monolayer based approach 
using small molecule Smad inhibitor SB431542 on top of Noggin, which became a 
popular neural induction method known as the dual-SMAD inhibition protocol 
(Chambers et al., 2009).  Later, it was discovered that LDN-193189 can efficiently affect 
all signalling cascades induced by BMP (Boergermann et al., 2010), offering a 
replacement option for Noggin in more recent published works. 
Since neuronal subtype is dependent on the exposure to morphogens, the potential of 
the neural stem cells (NSCs) generated via the dual-SMAD protocol to respond to further 
patterning factors was tested. By exposing them to SHH and FGF8, the generation of TH+ 
neurons was achieved, while motoneurons were derived after exposure to BDNF (brain-
derived neurotrophic factor), ascorbic acid, SHH and retinoic acid (RA) (Chambers et al., 
2009).  These results were highly valuable since a monolayer culture in combination with 
chemically defined culture medium allow the addition of the required combination of 
patterning factors, where cells are thought to be exposed to uniform concentration of 
these factors, thus promoting a more homogeneous method for in vitro differentiation. 
Later on, other laboratories (including ours) have designed differentiation protocols to 
generate several classes of neurons, such as dopaminergic neurons (Jaeger et al., 2011; 
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Nolbrant et al., 2017), striatal medium spiny neurons (MSNs) (Arber et al., 2015) and 
cortical interneurons (Cambray et al., 2012; Maroof et al., 2013).  
In the field of developmental neuroscience and despite the clinical relevance of cortical 
interneurons, most of our knowledge about human cortical interneurons relies on post-
mortem studies of the human brain and animal models.  Therefore, in vitro 
differentiation of hPSCs can be used to gain insights into specific mechanisms guiding 
cortical interneurons development in humans or modelling neuropsychiatric diseases. 
Currently there is not an efficient protocol for generating human cortical interneurons 
in vitro. However, the establishment of an efficient protocol for the in vitro derivation 
of human interneurons is an area of intense research. An overview of the published 
methods is provided in the following section.  
 
 
 
1.3.1.2 Generation of cortical interneurons from hPSCs 
Several protocols for inducing cortical interneuron fate have been published to date. 
These protocols were based on the combinatorial activation or inhibition of key 
signalling pathways aiming to mimic cell signalling conditions in the ventral 
telencephalon, where the MGE arises.  Within this region, a concerted action of SHH 
activation along with WNT inhibition takes place. In the mouse embryo, the Wnt 
inhibitior Dkk1 gradient is opposed to the Wnt/β-catenin and together  mediates 
anterior-posterior patterning, hence the designed differentiation protocols employ 
WNT inhibitors to bias cell fate towards a rostro-ventral character, which is further 
ventralised by activating SHH pathway (Tyson et al., 2015). 
By applying the current understanding of cell signalling within the MGE, in 2013 Nicholas 
and colleagues showed that differentiation of hPSCs into functional interneurons 
required an extended timeline mimicking human development.  They differentiated the 
hPSCs NKX2.1-GFP reporter via embryoid bodies treated with SB431542, DKK1, along 
with an early activation of SHH pathway (using purmorphamine). This approach resulted 
in 74.9±2.1 % of GFP+ cells. Most of the cells co-expressed FOXG1. By day 35 GFP+ cells 
were sorted and cultured on adherent conditions onto mouse glial cells. This method 
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gave rise to 40.6% of SST+ cells after 30 weeks of differentiation, 1.5% of PV+ and 77.7% 
of CR+ (Nicholas et al., 2013). The data presented by Nicholas suggests that 37.1% of the 
CR+ population was uniquely labelled CR+. Although it has been reported that NKX2.1 is 
co-expressed with COUPTF-II in the dorsal MGE  in mouse and humans (Cai et al., 2013; 
Hansen et al., 2013), and this region has been suggested as the source of SST+/CR+ 
interneuron population in mouse (Fogarty et al., 2007).  Therefore data reported by 
Nicholas and co-workers suggest that 37.1% of uniquely label CR+ cells  were derived 
from NKX2.1+ cells, which raises the question of whether the human MGE gives rise to 
CR+ interneurons. Future investigations should be directed for answer this question.  
One year later, another differentiation protocol was reported using the embryoid body 
approach and a different WNT inhibitor (IWP2) and SHH agonist SAG (Kim et al., 2014). 
A novel aspect of this work was the addition of FGF8. The authors found that the 
activation of SHH signalling was accompanied by induction of a rostralising factor FGF8, 
along with induction of FGF15/19 which counteracts FGF8-effects. The authors 
proposed that exogenous FGF8 would further promote anterior character, thus 
enhancing MGE fate and supress CGE identity. They reported 1.53% of SST+, 0.87% of 
PV+ and 22.23% of CB+  (calbindin) cells out of total cell population (Kim et al., 2014). 
However, as this work did not involve a pre-selection of NKX2.1 cells prior to neuronal 
differentiation, it was not possible to directly compare the efficiency of this protocol 
with that of Nicholas et al., 2013. 
Also using NKX2.1-GFP reporter cells, a similar patterning approach was also 
experimented on monolayer culture by Maroof and Colleagues (Maroof et al., 2013). 
This protocol induces neutralisation of the NKX2.1-GFP reporter by applying LDN-
193189, SB431542 (dual-SMAD inhibition) along with promoting anterior-ventral 
character by using XAV939 during first ten days of differentiation. They showed that the 
combination of these three small molecules robustly induced forebrain fate in hPSC and 
iPSC lines.  In contrast to the two other methods above, this work demonstrated that 
early SHH activation was not required for inducing ventralisation, as the addition of SHH 
and purmorphamine from day 10 of differentiation (after neuralisation) strongly induces 
NKX2.1+ expression in more than 80% of cells and more than 90% of this population co-
expressed FOXG1. GPF+ cells were isolated and plated onto a layer of mouse embryonic 
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cortical cells (E13.5) to promote terminal differentiation and maturation. At day 62 of 
differentiation 40% of GFP+ population was SST+ and 5% PV+ (Maroof et al., 2013).  
The three protocols described above all generate a high proportion of NKX2.1 
population, suggesting that the initial patterning towards the MGE-like fate is relatively 
easy. However, terminal differentiation and maturation of interneuron subtypes were 
generally poor efficient and require an extended timeline. Therefore, more research is 
needed in order to improve the yield of interneuron classes, their maturation and 
possibly to shorten the time necessary for their generation. Due to efficiency, 
differentiation timeline and monolayer culture, in this thesis a modified version of the 
protocol of Maroof and colleagues (reported in Noakes et al., 2019) was employed.  
 
 
1.3.1.3 Direct programming of human cortical interneurons 
One of the most intriguing questions in developmental biology was concerned to 
whether cell differentiation depends on changes in the gene expression program. This 
question started to be addressed when Sir John Gurdon transferred the nuclei of 
intestinal epithelium cells into an enucleated Xenopus egg, thereby generating embryos 
capable of developing into tadpoles (Gurdon, 1962). Later on this technique, known as 
nuclear transfer enabled animal cloning (Wilmut et al., 1997). These studies 
demonstrated that a differentiated state might be reversed by the activity of certain 
molecular regulators. More recently, reprograming of mouse and human fibroblast into 
iPSCs was achieved by forced expression of key transcription factors (Takahashi and 
Yamanaka, 2006). Since these works were published, a plethora of research has 
evidenced that although embryonic development is a unidirectional process, cell fate is 
not, since by exposing the nucleus to the action of specific factors, cell fate can be 
manipulated (extensively reviewed in Cruz-Santos et al., 2016). 
Soon after establishment of the first iPSC line, searching for factors to allow direct 
reprogramming from one somatic lineage to another became a very active research 
field. Amongst these, combinatorial expression of Ascl1, Brn2 and Myt1l (neural-lineage-
specific transcription factors) has been shown capable of directly reprograming mouse 
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fibroblasts into neurons (namely induced neurons, iNs) (Vierbuchen et al., 2010). One 
year later,  MYT1L, BRN2 and miR-124 were successfully used for reprogramming 
postnatal and adult human fibroblasts to iNs (hiNs) (Ambasudhan et al., 2011). 
Initially, cell reprogramming was achieved through lentiviral expression of selected 
transcription factors; however, the field has evolved to use other molecules, such as 
micro-RNAs or small molecules. Technical approaches have also evolved in a way that 
enhanced expression of selected genes can be achieved by using a modified 
CRISPR/Cas9 (Clustered regularly interspaced short palindromic repeats/ CRISPR-
associated protein) system (Kabadi et al., 2014). This system employs a mutated Cas9, 
which contains an inactive nuclease domain (named dCas9). In addition, dCas9 is fused 
to two trans-activators domains (Vp64-dCas9-Vp64) to promote transcriptional 
activation of the targeted gene. This modified version of the CRISPR/Cas9 system has 
been used to mediate direct reprogramming of fibroblast into neuronal cells by targeting 
the promoter of Brn2, Ascl1 and Myt1l (Black et al., 2016). This report exemplifies the 
use of CRISPR/dCas9 system to directly regulate gene expression for the purpose of 
“programming” a desired cellular fate.   
The application of the generated of hiNs is limited by lacking regional specificity identity. 
Therefore, the next step forward is the derivation of specific neuronal fates. Which is 
particularly relevant for neuronal types that are late-born and require long term 
maturation as the case of PV+ interneurons. By establishing reprogramming conditions 
it might be possible to bypass the laborious process of differentiation of interneurons 
by their direct conversion from other cell types. A first attempt  to convert  human iPSCs 
into GABAergic neurons was reported in 2015 by forced expression of Foxg1, Sox2, 
Ascl1, Dlx5 and Lhx6 (Colasante et al., 2015). Using this approach around 30% of   hiPSCs 
turned into GABAergic neurons with a large number of them expressing PV+. However, 
the authors did not detect fast spiking activity in these PV+ iNs neurons, which is a key 
characteristic of PV+ interneurons. Moreover, PV+ neurons reprogrammed from mouse 
fibroblasts (using the same set of transcription factors) lost PV expression after 
transplantation (Colasante et al., 2015).  
Although the above set of genes have been shown as important players in the  
development of MGE-derived cortical interneurons, their failure to produce fast spiking 
neurons and maintain PV+ phenotype might suggest that other factors may be lacking in 
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the programming cocktail. However, this report serves a proof of concept that by 
manipulating gene expression using the CRISPR/dCas9 system, interneuron 
reprogramming can be achieved, and opens a new path to functionally identify 
unknown-interneuron-determinants. 
Later in 2016, Sun and co-workers found that lentiviral expression of three transcription 
factors ASCL1, DLX2 and LHX6 along with microRNA9/9* and micro-RNA-124 generates 
an enriched population of cells displaying characteristics of GABAergic cells from hPSCs. 
These induced GABAergic neurons (iGNs) exhibit mature properties within 6-8 weeks. 
iGNs generated by this approach were co-cultured with rat glia to promote functional 
maturation. After 42 days post-transduction, 84.5 ± 3.5% of the cell population was 
GABA+. Further characterisation of the interneuron classes obtained by this approach 
revealed that 24.3 ± 4.6% were SST+, 11.6 ± 3.0% CR+, 6.5 ± 2.4 % CB+ and 5.4 ± 2.0% 
NPY+ (Sun et al., 2016). 
In addition to the reports above, a non-integrating transgene expression system for 
generating iNs has been tested in mouse fibroblast. This might be a promising 
reprogramming strategy to minimise safety risks for generating human interneurons for 
clinical purposes. In this approach, the adenoviral overexpression of Ascl1 along with the 
addition of forskolin at 20 µM, turned 77.2% of cells into PV+ and the vast majority co-
expressed Tuj1 by 7 days after adenoviral transduction. By 14 days, 99.6% of them were 
GABA+ (Shi et al., 2016).  However, this approach needs to be tested in human cells. 
In summary, although several transcription factors and micro-RNAS have been 
employed for programming cortical interneuron-fate from hPSCs, the generation of 
cortical interneurons remains poor efficient, with unstable phenotype and particularly 
time consuming. However, the works outlined above provided proof of principle that 
gene transcriptional activation, enforced expression of transgenes, microRNAS and 
addition of small molecules, or combination of these factors is a valid approach for 
generating defined neuronal subtypes, such as cortical interneurons. Additionally recent 
findings of genes expressed in prospective PV or SST populations provide a starting point 
for identifying new interneurons determinants in order to design improved 
differentiation paradigms.  
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1.4 Aims 
Human cortical interneurons derived in vitro provide a powerful tool for modelling 
normal development and interneuron associated diseases. However, current methods 
for producing these cells are low efficient and their functionality remains poorly 
characterised. 
The first aim of this thesis concerns the generation of a LHX6–mCherry reporter for 
tracking the development of human cortical interneurons with a long term goal for using 
it as a screening platform for the identification of unknown interneuron determinants. 
Such new insights into the control of MGE differentiation would in turn facilitate the 
design of improved interneuron differentiation protocols.  
The second objective was to apply the generated reporter in investigating the role of 
TGFβ signalling in MGE induction and interneuron differentiation.  
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2. Methods and materials 
 
 
2.1 Cell Culture 
Cell culture was carried out following aseptic techniques under a laminar flow hood 
(Maxisafe 2020, Thermo Scientific). Cultures were incubated at 37 °C, 5% CO2 (Galaxy 
170 R, New Brunswick).  
 
2.1.1 hPSCs maintenance 
Human pluripotent stem cells used in this study include H7cells and the dual reporter 
line (PV-gfp/LHX6-mCherry) derived from H7. Cells were cultured on 6-well multi-dishes 
(VWR) coated with Matrigel (VWR). Culture media was changed daily and cells were 
passaged when they reach around 80% confluence. For passaging, E8 media was 
aspirated, cells were washed once with 2 ml of PBS (Invitrogen). Cells were then 
incubated 4 min at room temperature (RT) in 1 ml of 0.02% EDTA (sigma). EDTA was 
then aspirated and 1.5 ml of E8 media added. Cells were gently scraped with a 5 ml 
serological pipette and seeded into Matrigel-coated 6 well plates in a 1:6 ratio.  
 
2.1.2 hPSCs freezing and thawing 
For freezing hPSCs, each well at 80% confluence was treated for 30 min with Rock (Rho-
associated kinase) inhibitor (Stem Cell Technologies). Cells were detached as described 
in 2.1.1, except that cells were kept in larger clusters. Cells were centrifuged at 940 rpm 
for 4 min and resuspended in 1 ml of E8 media with 10% DMSO (Sigma). 1 ml of cell 
suspension was placed in a cryovial (VWR) and transferred to -80 °C freezer temporarily. 
Afterwards, cells were kept in liquid nitrogen for long-term storage.  
To thaw hPSCs, a cryovial was taken from the liquid nitrogen and gently swirled in a 
water bath at 37 °C. Cell suspension was placed into a 15 ml conical tube (Fisherbrand) 
and 9 ml of E8 media were slowly added, followed by centrifugation at 940 rpm for 4 
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min. Cells were resuspended and plated into a 6-well plate previously coated with 
matrigel.  
 
2.1.3 Neural differentiation of hPSCs 
To induce MGE differentiation, two wells containing hPSCs 80% confluent were used. 
Cells were detached as described in 2.1.1 and plated into a 12-well plate, which was 
previously coated with reduced growth factor matrigel (VWR) for 2 hours at 37 °C. Cells 
were kept in E8 media (Day 0) and next day the media was aspirated, washed once with 
D-PBS and media was replaced by N2B27 (Day 1). 150 ml  of N2B27 was prepared as 
following: 100 ml DMEM-F12 (Gibco), 50 ml Neurobasal (Gibco), 1 ml N2 supplement 
(Invitrogen), 1 ml B27 without retinoic acid (Invitrogen), 2 mM L-glutamine (Gibco), 1x 
Mycozap (Lonza), 0.1 mM β-mercaptoethanol (Gibco).  
From day 1 to day 10, cells were treated with: LDN-193189 (100 nM, Tocris), SB-431542 
(10µM, Tocris) and XAV-939 (2 µM, Stratech). For cortical differentiation cells were 
treated only with LDN-193189 (100 nM, Tocris) and SB-431542 (10µM, Tocris). At day 
10 cells were passaged as next described: 1 hour before passaging, cells were treated 
with Rock Inhibitor and incubated a 37 °C. After incubation media was collected in a 15 
ml centrifuge tube and cells detached applying EDTA for 3 min at RT. EDTA was aspirated 
and the previously collected media was returned to the cells. Using a 5 ml serological 
pipette, cells were gently scratched keeping them as big clusters. Cells were plated in a 
2:3 ratio in 12-well plates coated with fibronectin (15 µg/ml, Sigma) for 1 hour at 37 °C. 
Next day, media was changed and replaced by N2B27 plus SHH (200 ng/ml; R&D) and 
purmorphamine (1µM; Millipore). SHH and PM were added to the media from day 11 
until day 20. For Cortical differentiation cells were seeded onto fibronectin in N2B27 
media without inhibitors or growth factors.  
 On day 19, a second passage was carried out, as above described but this time 
dissociating cells as single cells using Accutase (Life Technologies). Cells were counted 
and plated onto poly-D-lysine/laminin-coated plates. 200,000 cells/well were plated 
onto 24-well plates, double number of cells were plated onto 12-well plates.  From day 
20 to day 25 cells were grown in N2B27 without any growth factor or inhibitor, 
afterwards the media was replaced by N2B27 with retinoic acid plus BDND (10 ng/ml; 
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Peprotech). For kinetic of mCherry experiment cells were treated with demecolcine 
(Sigma) at 1 µg/ml and incubated for 2 hours at 37 °C, 5% CO2. 
For TGFβ signalling modulation, cells in MGE differentiation conditions were either 
treated with the dual kinase TβRI/II inhibitor LY2109761 (Santa Cruz) at 5µM from day 
11-20., or with TGFβ3 (R&D systems) at 1ng/ml from day 14-20. To promote exit of the 
cell cycle cells were treated with 2 μM PD0332991 (Sigma) and 10 μM DAPT (Tocris) 
from day 35 to day 60.  
 
2.2 Gene targeting 
To generate the dual reporter stem cell line, a multiplex CRISPR/Cas9 assembly system 
kit (Addgene kit 1000000055) was employed to express up to 3 gRNAs (guide RNAs) 
along with the Cas9 enzyme. This plasmid was co-delivered to the cells with a targeting 
vector to mediate homologous recombination. The targeting vector encodes the 
sequence of GFP or mCherry flanked by homology arms (HA) as described in detail in 
next section.  
 
2.2.1 Plasmids generation 
Three gRNAs were designed around the last coding codon of PV and LHX6 loci using the 
CRISPR design tool (crispr.mit.edu). The complementary sequence of each gRNA was 
designed and BbsI overhangs were added. The sequence of the gRNAs for PV and LHX6 
knock in generation is listed in Table 2.1. The gRNAs were phosphorylated with T4 PNK 
(New England Biolabs, NEB) and annealed using the following program: 37 °C- 30 min, 
95 °C-5 min, ramp down to 25 °C at 5 °C/min. Each annealed and phosphorylated gRNA 
was cloned separately into the pX330A-1x3, pX330S-2 and pX330S-3 plasmids. Briefly 
1.5 µg of each plasmid were overnight digested with BbsI (NEB) at 37 °C. After digestion, 
BbsI was inactivated at 65 °C for 15 min. 1 µl of the phosphorylated and annealed gRNAs 
duplex was ligated with 100 ng of the BbsI digested plasmid using Quick ligase (NEB). 
The ligation reaction was treated with plasmid safe exonuclease (epicentre) 30 min at 
37 °C. 5µl of the ligation was transformed into the E. coli strain XL1-Blue (agilent 
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technologies); plated onto LB with the corresponding selection antibiotic and overnight 
incubated at 37 °C.   
Next day eight colonies were picked and cultured in LB media with the antibiotic 
selection and cultured overnight at 37 °C. Plasmidic DNA was extracted by miniprep and 
screened by double digestion with BbsI and EcoRI to identify the clones with the inserted 
gRNAs, in which the BbsI site was destroyed resulting in a linearised plasmid.  One clone 
of each plasmid with the inserted gRNA was selected and assembled into the pX330A-
1x3 plasmid by a golden gate reaction. For this, 300 ng of pX330S-2 and pX330S-3 was 
mixed with 150 ng of pX330-1x3, BsaI (NEB) and Quick ligase (NEB). The reaction was 
carried out with the following program: 25 cycles of 37 °C-5 min, 16 °C-10 min; hold at 4 
°C. 5µl of the ligation were transformed into XL1-Blue strain and overnight cultured at 
37 °C onto LB plates plus antibiotic. Clones were picked and cultured in LB media with 
antibiotic. Plasmids were extracted and screened by double digestion with AflIII (NEB) 
and KpnI (NEB). Clones containing three assembled gRNAs released a fragment around 
1.4 kb.  
In parallel, targeting vectors were designed encoding the reporter gene and a selection 
cassette, flanked at each end by 3’ and 5’ homology arms respectively. Diagrams 
showing the design of both targeting vectors are showed in Figures 3.2 and 3.3.  
  
Table 2.1| Sequence of the gRNAs use for targeting LXH6 and PV genes 
Guide Forward sequence  Complementary sequence  
LHX6 Guide 1  TTTTTCAGTACTAACGCTGC AAAAAGTCATGATTGCGACG 
LHX6 Guide 2 CACTTCCGCATCTGCCCGT GTGAAGGCGTAGACGGGCA 
LHX6 Guide 3 TCAGCCGCTGAGATCCAGTG AGTCGGCGACTCTAGGTCAC 
PV Guide TAAGAAGCACTGACTGCCCC ATTCTTCGTGACTGACGGGG 
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2.2.2 Nucleofection and hPSCs lines derivation  
hPSCs were treated with Rock Inhibitor  one hour before nucleofection. Cells were 
detached with gentle cell dissociation reagent (Stem Cell Technologies) and dissociated 
as a single cell suspension. The gRNAs encoding plasmid was co-transfected with the 
targeting vector using the amaxa 4D-nucleofector protocol (Lonza), in a 1:3 (gRNAs: 
targeting vector) proportion for PV targeting and 1:7 for LHX6. Transfected cells were 
plated onto matrigel and cultured in TeSR-E8 media (Stem cell technologies) plus 
RevitaCell (Life technologies). 48 hours after nucleofection, the appropriate antibiotic 
was added to start the selection of nucleofected cells. After selection process, cells were 
plated in limiting dilution to obtain clonal populations. Two weeks after nucleofection, 
individual clones were picked, cultured and genotyped by PCR. Correctly targeted clones 
were subjected to a second round of nucleofection. Expression plasmids encoding FLP 
or CRE recombinase were nucleofected as above described. Individual clones were 
picked and genotyped. To test the loss of CMV-HygroTK, a portion of each clone was 
cultured in presence of hygromycin. The clones which died with the antibiotic treatment 
were selected, expanded and frozen.  
The loss of resistance to neomycin was tested by PCR and confirmed by adding neomycin 
to the media to a portion of the clones. The clones which died with neomycin treatment 
were selected, expanded and used for differentiation.  
 
2.2.3 PCR-based genotyping 
2.2.3.1 Genomic DNA extraction  
Media was aspirated  and cells were treated with lysis buffer consisting of 10 mM tris, 
pH 8.0, 50 mM EDTA, 100 nM NaCl , 0.5% SDS (all components from sigma) and 
supplemented with proteinase K to a final concentration of 0.5 mg/ml. Cells were 
returned to the incubator for at least 4 hours. The lysate was transferred into an 
Eppendorf tube and an equal volume of isopropanol was added and the tube carefully 
mixed and centrifuged for 20 min, 4 °C at full speed. The supernatant was removed and 
the pellet washed with 70% ethanol and centrifugated for 10 min, 4 °C at full speed. 
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Pelleted DNA was air-dried and resuspended in milli-Q water, DNA concentration was 
measured with a Biospectrometre from Eppendorf.  
 
2.2.3.2  PCR  and electrophoresis  
PCR was carried out to genotype clones transfected with the PV- targeting vector, LHX6-
targeting vector or after removing the selection cassettes. A particular program was 
designing for each product to be amplified and the reaction was setting up following the 
guidelines for the specific polymerase in use. The main parameters changed among 
programs were temperature of extension, which is the temperature at which the 
polymerase in use works, extension time that considers the time needed for the 
polymerase to amplify the product of interest, as well as the annealing temperature 
depending on the primers in use. All the primers used for genotyping are listed in Table 
2.2. The polymerases used were Taq polymerase from New England Biolabs or the 
SequalPrep long PCR kit from Thermofisher. The PCR product was analysed on an 
agarose gel between 1-2% of concentration depending on the amplicon size. 
 
Table 2.2| Sequence of the primers used for genotyping 
Purpose Forward 
Oligo  
Sequence  Reverse 
oligo  
Sequence  
WT LHX6  
locus 
Out5'HA
_LHX6_F 
 
TCAGCCACTATGGTCAC
GGT 
 
3'HA_LHX6
_R 
 
 
TGGATGCGGAGGTGGGT 
 
5’ LHX6 
genotyping 
Out5'HA
_LHX6_F 
 
TCAGCCACTATGGTCAC
GGT 
 
 
mCherry_F 
 
 
GGGCGAGGAGGATAACAT
GG 
 Selection 
cassette 
removal  
 
Neo_F 
 
 
GCATCGCCTTCTATCGCC
TT 
 
 
 
SA_LHX6_R 
 
 
CATTCCCTGTCTATCCCCG
C 
 3’ LHX6 
genotyping 
SV_40_
R 
 
 
GGGAGGTGTGGGAGGT
TTTT 
 
 
3'HA_LHX6
_R 
 
 
TGGATGCGGAGGTGGGT 
 
5’ PV 
genotyping 
PVALB-
p7F 
 
 
TTGGCCAGGCTGGTCTC
AAACTCC 
 
 
 
5’HYGRO_R
2                                    
 
 
TCGACAGACGTCGCGGTG
AGTTC 
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2.3  Cell analysis  
2.3.1 Immunocytochemistry 
Cells were washed with PBS (Sigma) and fixed with 3.7% PFA (Sigma) for 15 min at 4 °C. 
Cells were permeabilised by washing twice with PBST (0.3% Triton X-100 in PBS) for 10 
min at RT. For nuclear proteins, cells were washed for 5 min at RT with 33% and 66% 
methanol respectively, then with 100% methanol for 20 min at -20 °C, before being 
returned to PBS washing in the reverse order. Cells were blocked in blocking solution 
(1% BSA/3% serum in PBS) for one hour at RT, and then incubated with the primary 
antibody in blocking solution overnight at 4 °C. Table 2.3 lists all primary antibodies used 
for immunocytochemistry experiments. 
Next morning cells were washed three times with PBST for 5 min each at RT, following 
with incubation with the secondary antibody in blocking solution for 1 hour at RT. From 
this point cells were kept in dark. After secondary antibody cells were washed three 
times with PBST for 5 min at RT with DAPI (1:3000 in PBST) added in the last wash for 
nucleus counterstain. Cells were washed again three times with PBST for 10 min at RT. 
PBST was removed and a drop of fluorescence mounting medium (Dako) was added. A 
coverslip was placed and images acquired using an inverted microscope (Leica 
DMI6000B). Images were processed using the Leica Application Suite software, ImageJ 
and CellProfiler.  
 
2.3.2 Flow cytometry 
For flow cytometry experiments, cells were dissociated with accutase (Life 
Technologies) for 5-10 min (depending on the differentiation stage) at 37 °C. After 
incubation, cells were washed in cold PBS and centrifuged at 960 rpm for 4 min. Cells 
were resuspended in 100 µl cold PBS and 100 µl of cold DAPI/PBS (1:3000) and collected 
in a FACS tube with cell strainer (VWR). Data was acquired using a Fortessa analyser 
(BD). H7 cells at the same stage of differentiation were using in each time point as a 
negative control, DAPI staining was used to discard dead cells from the analysis.   
34 
 
Table 2.3| Antibodies used for immunocytochemistry  
Antigen Species Supplier Code Dilution  
ChAT GOAT MILLIPORE AB144P 1:100 
COUPTF II Mouse Perseus & proteomics  1:100 
CALRETININ Rabbit Swant CR 7697 1:500 
CTIP2 Rat Abcam Ab18465 1:500 
FOXG1 Rabbit Abcam ab18259 1:250 
GAD67 Mouse Millipore mab5406 1:500 
LHX6 Rabbit  Santa cruz sc98607  1:500 
mCherry CHICKEN ABCAM 
ab205402 
1:500 
NeuN RABBIT MILLIPORE  1:500 
NKX2.1 Rabbit Abcam Ab76013 1:1000 
OCT4 Goat Santa cruz Sc8628 1:500 
OLIG2 Goat R&D systems AF2418 1:200 
PAX6 Mouse DSHB  1:1000 
PARVALBUMIN Mouse Sigma P3088 1:100 
SATB2 Mouse Abcam ab51502 1:50 
SOMATOSTATIN Rat Millipore MAB354 1:50 
TBR1 Rabbit Abcam ab31940 1:500 
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2.3.3 Gene expression analysis 
2.3.3.1 RNA extraction   
Cells in 12 well plate were lysed with 1 ml of Tri reagent (Sigma), then 200 µl chloroform 
were added and the samples were vigorously shaken for 15 seconds. Samples were then 
allowed to stand for 10 min at RT before centrifugation at 12,000 x g  for 15 min at 4 °C. 
Aqueous phase was transferred into a new tube and thoroughly mixed with 500 µl 
isopropanol. Samples were left to stand at RT for 10 min and centrifuged at 12,000 x g 
for 10 min at 4 °C. The liquid was removed and the pellet was washed with 1 ml  75% 
ethanol followed by centrifugation at 7,500 x g for 5 min at RT. The RNA pellet was left 
to dry and then dissolved in 20 µl nucleases-free water. 
 
2.3.3.2 DNAse treatment 
RNA concentration was measured using a Spectrometer (Eppendorf) and 10 µg were 
treated with 1µl of turbo DNase (Ambion). Samples were incubated at 37 °C for 30 min. 
After incubation 2 µl of DNase inactivation reagent was added and incubated for 5 min 
at RT mixing samples regularly. Then samples were centrifuged at 10, 000 x g for 1.5 min. 
The supernatant, containing the RNA was transferred to a new tube. 
 
2.3.3.3 Reverse transcription  
After DNase treatment, reverse transcription was carried out using the qScrip cDNA 
synthesis kit (Quanta). With that purpose  1 µg RNA was mixed with 1 µl qScript R plus 
4 µl  qScript Reaction Mix (5X), the volume was adjusted to 20 µl  with nuclease-free 
water. The reaction was performed with the program next detailed: 22 °C -5 min, 42 °C- 
50 min, 85 °C-5min. After completion of the reaction, cDNA was diluted 1:10 in 
nucleases-free water for qPCR amplification   
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2.3.3.4 Real time PCR 
Once cDNA was obtained, the SYBR Mesa Green master mix (Eurogentec) was used for 
qPCR. Briefly 5 µl reaction buffer was mixed with 100 nM of the forward and reverse 
primers and made up to 10 µl with endonucleases free water. 9 µl of the mix was placed 
into each well of a 96 well-plate and 1 µl of diluted cDNA was added. Each sample was 
assayed in triplicate. The reaction was perform using the Bio-rad CFX Connect Real-Time 
System and next program: 94 °C for 4 min, followed by 40 cycles of 94 °C -30 sec, 60 °C-
15 sec and 72 °C- 30 sec. Melting curve analysis was performed from 65 to 95 °C to 
corroborate the specificity of the of the PCR product. Oligos were designed using the 
online PrimerBLAST tool from NCBI and their efficiency evaluated following the 
guidelines from Bio-Rad. Primers used for qPCR experiments are listed in Table 2.4. 
 
Table 2.4| Sequence of primers used for qPCR 
 
 
 
 
 
Gene Forward Reverse 
FAPB7 GGATTGGGAGGAACTCGACC AGGGTGGGCAAAAATCCAGT 
GAD67 CGTCTTCGACCCCATCTTCGT CGCAGATCTTGAGCCCCAGTT 
LHX6 GACGACATCCACTACACCCC GGCCCATCCATATCGGCTTT 
SOX6 CTGCCTCTGCACCCCATAAT CGCTCTGGGGTTCCAAAAGT 
STMN2 CTCAGAAGCCCCACGAACTTT TCGCTCGTGTTCCCTCTTCT 
TOP2A ACCAAGAATCGCCGCAAAAG ACAGATTTTGCCCGAGGAGC 
β-Actin TCACCACCACGGCCGAGCG TCTCCTTCTGCATCCTGTCG 
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2.3.3.5 Fold change calculation  
Data collected by the CFX Manager Software (Bio-rad) and exported to Microsoft excel 
for analysis. To calculate the relative difference in expression level of the target gene, 
data was normalised to the housekeeping gene β-actin and compared to the gene 
expression at the pluripotent state, using the Livak method where the normalised 
expression ratio= 2-ΔΔCt. Fold change at each time is presented as the mean of 2 biological 
replicates ± SEM. 
 
2.3.4 Chromosome preparation for karyotyping  
Sub-confluent cells were treated with demecolcine (Sigma) to a final concentration of 1 
µg/ml and incubated for 1 hour at 37 °C, 5% CO2. Cells were then dissociated to a single 
cell suspension using Gentle Cell Dissociation reagent (Stem Cell Technologies), 
incubating 8 minutes at 37 °C. Cells were collected and washed twice with PBS 
(Invitrogen) and centrifuged for 4 min at 1000 rpm. Cells were resuspended in 2 ml of 
PBS and 6 ml of hypotonic 0.075 M KCl (Sigma) were added, then cells were incubated 
for 15 min at 37 °C. After incubation, additional 4ml of 0.075 KCl were added and cells 
were collected by centrifugation 4 min at 900 rpm. The supernatant was aspirated 
leaving 300 µl to resuspend the cell pellet by flicking. Dropwise and flicking 
simultaneously, 4 ml of pre-chilled (-20 °C) methanol/acetic acid (3:1, VWR chemicals) 
were added. Cell suspension was incubated for 30 min at room temperature. Cells were 
centrifuged for 4 minutes at 800 rpm and resuspended with additional 4 ml of 
methanol/acetic acid. Cells were collected as previously and resuspended in   the 
remaining 300 µl of methanol/acetic acid. Cell suspension was dropped onto a slide (pre-
chilled and laid on angle) from a height of 30 cm. Slides were air dried and chromosome 
spread was stained and mounted using a mix of mounting media (DAKO) with DAPI 
(1:3000).  Images of chromosome spreads were obtained with an inverted microscope 
(Leica DMI6000B). Images were processed using the Leica Application Suite software 
and counted on ImageJ. 
 
 
38 
 
2.3.5 EdU labelling assay 
Cells going through the S-phase of the cell cycle were labelled using the Click-iT EdU 
Assay kit from Invitrogen. Control cultures or LY-treated cultures were plated at 200000 
cells per well onto a four well-plate and incubated in EdU at a final concentration of 10 
µM, at 37° C. For pulse analysis cells were incubated for 2 hours or for increasing periods 
of time (2, 4, 8, 16 and 24 hours) for cell cycle length determination. Cells were fixed in 
3.7% PFA (Sigma) for 15 min at 4 °C, following with permeabilisation with 0.5% of Triton 
X-100 in PBS.  Cells were incubated at room temperature for 20 minutes in the reaction 
cocktail, prepared as per manufacturer’s protocol. If co-staining is needed, it was carried 
out before the EdU detection. After EdU detection, nuclei stain with DAPI was performed 
and mounting media added. At least 3 fields/well were imaged in an inverted 
microscope (Leica DMI6000B). Images were processed using the Leica Application Suite 
software and manually counted using ImageJ. 
 
2.3.6 Cell cycle length estimation 
To estimate the length of the cell cycle, six fields from 2 biological replicates were 
counted at each time point of the EdU cumulative labelling. The percentages of the 
NKX2.1+_EdU+ and NKX2.1-_EdU+ in control and LY conditions were plotted against time. 
A linear regression was performed, and the values of the slope (m) and y-intercept (b) 
of the linear equation were used to calculate the values of  cell cycle length (tc) and S-
phase length (ts), using the Nowakowski equation: 
GF(t) = (GF/tc)t +  GF(ts/tc) 
Where: 
GF= Growth fraction in cell population 
m=GF/tc   thus  tc=GF/m 
b= GF(ts/tc)  thus   ts=( b*tc)/GF 
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2.3.7 Statistical analysis 
Data from  immunocytochemistry was processed  by counting positive cells from 3 fields 
of  two or three independent differentiations (n=9 or n=6), unless otherwise stated. Data 
is presented as the mean percentage ± SEM. Flow cytometry was presented as the mean 
of the cell percentage± SEM. For flow cytometry analyses cells were collected from 3 
wells of  at least 2 independent differentiations (n=6 or n= 9). Gene expression profile is 
expressed as mean fold change ± SEM from RNA extracted at each time-point, for 
control conditions and LY-treatment from two independent differentiations (n=2). Fold 
change calculation was performed as described in section 2.3.3.5. For comparing means 
of two groups a two-tailed t-test was performed after analysing normal distribution with 
the Shapiro-Wilk test and equality of variances with Levene’s test. When no normal 
distribution was found, a Mann Whitney U-test (non-parametric test) was carried out. 
To compare more than two groups a one-way ANOVA was conducted with a post-hoc 
Tukey. Significant differences were labelled as follows: * P < 0.05, ** P < 0.01, ***P < 
0.001.  
  
40 
 
3. Generation of  LHX6-mcherry/PV-GFP dual reporter  hPSC  line 
 
 
3.1 Introduction 
The ability of hPSCs to give rise to any cell of the body promises their application as an 
in vitro model for studying cell differentiation in health and disease (Murry and Keller, 
2008; Reubinoff et al., 2000). Such application is especially useful to study the 
development of clinically relevant cell linages, which are not easily accessible. One such 
example is cortical interneurons, the dysfunction of these cells and/or mutations in key 
genes for their development have been related to neurodevelopmental disorders 
(Batista-Brito et al., 2009; Del Pino et al., 2013; Marin, 2012; Wohr et al., 2015). 
Nonetheless, the potential of hPSCs could not be fully exploited unless specific cell 
populations can be faithfully identified. The creation of knock in reporter lines allow the 
visualisation in real time of the dynamic expression of genes of interest (Goulburn et al., 
2011; Zwaka and Thomson, 2003). Moreover, reporter cells can facilitate the 
identification of cell populations committed to a certain fate, the optimization of 
efficient differentiation protocols as well as the isolation of pure cell populations for 
downstream applications, such as transplantation and drug screening.  
The generation of knock in reporter lines involves the use of gene editing technology 
called gene targeting. This technique utilises the endogenous DNA repair mechanism of 
the cell through homologous recombination, which requires a targeting vector 
containing the desired genetic modification to be introduced into the locus of interest. 
As gene targeting involves homologous recombination, the targeting vector should 
contain two segments of DNA homologous to the genomic region to be targeted 
(referred as Homology Arms HA) (Thomas et al., 1992; Thomas et al., 1986). Although 
homologous recombination has been extensively used in generating  mouse models via 
the generation of engineered mouse embryonic stem cells, classic gene targeting  in 
hPSCs has proved challenging and  hence less exploited (Zwaka and Thomson, 2003). 
However, the landscape has changed in recent years due to the rapid advance of the 
CRISPR/Cas9 genome editing technology (Li et al., 2015b; Zhu et al., 2015). In contrast 
to the conventional gene targeting methods, which rely on the rare events of 
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recombination, the use of the Cas9 nuclease along with sgRNA to generate double 
strand breaks in the target DNA increases the efficiency of gene targeting (Li et al., 
2015b).  CRISPR/Cas9 system in combination with classic replacement targeting vectors 
has allowed the generation of reporter cell lines via homologous recombination, that 
carrying  fluorescent reporters recapitulating the expression of  endogenous  genes of 
interest. 
Only few neural lineage/cell type defining genes have been targeted in hPSCs to date (Li 
et al., 2015a; Li et al., 2015b; Xue et al., 2009). Among them, the NKX2.1-GFP knock in 
line has been used for facilitating the development of cortical interneurons 
differentiation protocols (Maroof et al., 2013). Although NKX2.1 is necessary to maintain 
regional identity in the MGE, this transcription factor promotes both GABAergic cortical 
interneurons and cholinergic fates in the basal forebrain (Fragkouli et al., 2009; Sussel 
et al., 1999). Therefore, the percentage of NKX2.1+ cells in a differentiation culture does 
not provide an accurate readout for cells fated to become GABAergic cortical 
interneurons. NKX2.1 promotes GABAergic cortical interneuron and cholinergic neuron 
fate via transcriptional activation of LHX6 and LHX8 (also known as LHX7), respectively 
(Sussel et al., 1999). While NKX2.1 expression remains in cholinergic neurons 
(NKX2.1+/LXH8+),  it is downregulated in a subset of MGE- derived  interneurons once 
they exit the cell cycle (NKX2.1-/LHX6+). (Lopes et al., 2012; Sandberg et al., 2016; Sussel 
et al., 1999). Moreover, it has been proposed that post-mitotic downregulation of 
NKX2.1 distinguishes cortical interneurons from striatal interneurons. Post-mitotic 
NKX2.1 expression in striatal interneurons represses the expression of semaphorin3 
receptors (Neuropilin2), and in consequence NKX2.1+ interneurons become insensitive 
to semaphorin3 repulsive signals in the striatum which allows them to settle in there. In 
contrast, NKX2.1- interneurons, express Neuropilin2+ which makes them responsive to 
the repulsive cues from the striatum, hence guiding their position towards the cortex 
(Nobrega-Pereira et al., 2008). Thus NKX2.1 expression could be used as good reporter 
for detecting the acquisition of MGE fate and later on for striatal interneurons, whereas 
MGE-derivatives committed to cortical interneurons could be identified by lacking 
NKX2.1 expression (NKX2.1-/LHX6+). 
Since LHX6 expression is highly specific to the MGE derivatives fated to become cortical 
interneurons and that its expression is maintained in these cells, a LHX6 reporter would 
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provide a better tool than the NKX2.1-gfp knock in for identifying factors regulating 
GABAergic cortical interneurons fate. 
Out of the MGE, Lhx6 transcript is detected within subdomains of the first branchial 
arch, such as the oral aspect of the mandibular process and part of the maxillary process 
in the developing mouse at E10.5, where LHX6 expression is confined to the neural crest-
derived mesenchyme (Grigoriou et al., 1998). With regard to adult tissues, LHX6 has 
been suggested as a tumour suppressor in some kind of cancers, particularly lung cancer 
tissue displays LHX6 downregulation compared with its expression in adjacent lung 
normal tissues (Liu et al., 2013).  Additionally the hypermethylation in CpG islands of 
LHX6 serves as a sensitive methylation marker in carcinomas such as head and neck and 
in early diagnosis of cervical cancer (Liu et al., 2013). Since the presence of the Lhx6 
transcript during embryonic development is highly restricted to the head as above 
described, it is particularly important to ensure that LHX6-mCherry expression is assayed 
in an enriched MGE-like population, otherwise the evaluation of mesenchymal markers 
alongside MGE related-markers will be essential to establish that our studies are 
restricted to MGE-like cells.  
Furthermore, a hPSC reporter that defines specific cortical interneurons subtypes is 
currently not available, although a strategy to identify generic GABAergic neurons 
derived from hPSCs has been developed (VGAT-mCherry knock in line) (DeRosa et al., 
2015). Hence, I also aim to target the PV gene to label the PV+ interneurons, a clinically 
relevant interneuron subtype due its implications in autism and schizophrenia (Marin, 
2012; Wohr et al., 2015).  
PV function as a Ca2+-binding protein, therefore it is not surprising that PV is detected in 
muscles of higher vertebrates playing a role as a relaxation factor. PV is also found in 
other tissues such as bone, teeth, skin, prostate, seminal vesicles, testes and ovaries of 
rats. PV+ cells are also identified in developing human spinal cord mammals (Arif, 2009). 
While the presence of pan neuronal markers such as Tuj, NeuN or doublecortin would 
help to differentiate PV+ interneurons from non-neuronal cell types, the distinction 
between PV+ cortical interneurons and PV+ neurons localised in the spinal cord needs 
the consideration of the developmental origins of both PV+ populations. Since cortical 
interneurons are forebrain-derived, the evaluation of anterior markers (e.g. FOXG1) is 
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critical to discard the generation of the spinal cord neural types, which have caudal 
origin through the concerted action of Hox genes (Davis-Dusenbery et al., 2014). 
The available data of the expression of Lhx6 during development shows that LHX6 
transcript is found in head but, unlike the PV, it is not detected in the spinal cord 
(reported in Grigoriou, 1998 and in http://www.eurexpress.org/); hence, it is expected 
that within neural lineages, the combined expression of LHX6 and PV will label 
specifically MGE-derived cortical interneurons. 
In this chapter, I describe the generation of a dual reporter hPSC line (LHX6-mCherry/PV-
GFP) using the CRISPR/Cas9 genome editing technology. The long-term goal is to use this 
cell line as a tool to identify factors regulating cortical interneuron differentiation and 
associated molecular mechanism.  
 
 
3.2 Results 
 
3.2.1 Targeting the LHX6  gene 
3.2.1.1  LHX6-targeting vector design and sgRNA assembly 
The LHX6-targeting vector was designed to contain the p2A-mCherry coding sequence 
and a floxed neomycin drug selection cassette flanked by a 5’ (500 bp) and 3’ (500 bp) 
homology arms, respectively, which correspond to the 500 bp flanking the stop codons 
of LHX6. The p2A sequence was placed between the last coding codon of LHX6 and the 
start codon of mCherry. P2A codes for a self-cleavage peptide, which enables 
multicistronic expression by promoting the ribosome to skip the polypeptide bond 
between the last glycine and proline in the C-terminus of the p2A, yielding two proteins. 
The upstream protein linked to most of the p2A peptide, and the downstream protein 
bound to a proline in its N-terminus (Kim et al., 2011; Wang et al., 2015).  This targeting 
vector design allows bicistronic expression of LHX6 and mCherry.  
 
The self-cleavage peptides offers two remarkable advantages compared to IRES 
(Internal Ribosome Entry Site). Firstly, self-cleavage peptides render an equimolar yield 
of the proteins flanking the peptide. Secondly, the small length of the 2A peptides 
(around 63 bp) is almost 9 times smaller than IRES sequences ( around 500 bp) (Kim et 
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al., 2011). This is particularly advantageous, as the small length of p2A allows the design 
of smaller targeting vectors which are easier to manipulate.  Due to the working-
mechanism of the self-cleavage peptide, there are two essential considerations to 
ensure the targeting vector to be functional. Firstly, there must not be a stop codon 
between the LHX6 sequence and the p2A-mCherry sequence, and secondly the insertion 
must be in frame into the locus. This will ensure the targeted locus to be transcribed as 
a single transcript, which will be cleavage at the translation (Zhu et al., 2015). Both 
considerations were taken into account for the targeting plasmid design.  
 
In spite of the multiple advantages of self-cleavage peptides, the length of the peptide 
affects the cleavage efficiency, having a good efficiency when using a 19-aminoacid 
version and showing increased efficiency when employing longer versions (Donnelly et 
al., 2001). However, in heterologous context, the 2A peptide remains attached to the c-
terminal of the upstream gene, which may affect protein conformation or interfere with 
post-translational modifications when the authentic c-terminal is crucial for such 
modifications. In consequence shorter version of 2A peptides have been used at 
expense of cleavage efficiency  Additionally, in shorter 2A sequences the cleavage 
efficiency may be affected by the C-terminal of the upstream protein coding-gene or by 
sequences added for cloning purposes (Minskaia and Ryan, 2013). Therefore, the 
efficiency of the cleavage seems to be context-dependent and difficult to predict in 
advance whether a particular gene targeting might affect the cleavage efficiency of the 
2A peptide.  
 
For CRISPR assisted genome editing, three sgRNA were designed using the online tool 
(https://zlab.bio/guide-design-resources). These sgRNAs target the last coding exon 
(exon 9) of the human LHX6 gene. This gene has 12 transcripts, 9 of which are protein 
coding which use two different stops codons.  Therefore the gRNAs were designed to 
target both stop codons. (Figure 3.2A). The selected sgRNAs were those displaying 
higher score of target efficiency and low potential off-targets. Using the multiplex 
CRISPR/Cas9 assembly system kit (Sakuma et al., 2014), each gRNA was cloned into 
independent vectors and subsequently assembled through a golden gate reaction into 
the destination plasmid, which also encodes the Cas9 nuclease (Figure 3.1A). Cloning of 
sgRNAs into individual plasmids was verified by double digestion with BbsI/EcoRI. This 
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double digestion should produce a linearised plasmid when the sgRNA was inserted as 
the single BbsI site was destroyed following the insertion of the gRNA (Figure 3.1B). The 
assembly of the three gRNAs was screened by double digestion with KpnI/AlfIII, which 
releases the 3 assembled gRNAs in a 1.4 kb fragment (Figure 3.1C).  The resulting plasmid 
was named as Cas9/3xsgRNAs. 
 
 
 
 
 
 
Figure 3.1| LHX6-sgRNA cloning A) For targeting LHX6 gene, three sgRNA were designed to 
direct Cas9 around the stop codons in the exon 9 of LHX6. The gRNAs were added BbsI sites 
for cloning them into independent plasmids; which were assembled into a Cas9 expression 
plasmid. B) Individual clones were assayed by double digestion of plasmidic DNA with 
BbsI/EcoRI. The gel is showing plasmids harbouring a gRNA were the BbsI site was 
destroyed. Plasmids without sgRNA insertion display two bands indicating that BbsI site is 
preserved. C) The 3 gRNAs were assembled into the cas9 expression plasmid. Succesfully 
assembled plasmids were screening by double digestion with KpnI/AlfIII; which releases the 
region containing 3 sgRNAs. The resulting plasmid is named Cas9/3xsgRNA.  
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3.2.1.2 Generation of LHX6-mCherry reporter  
 
The LHX6-targeting vector and the Cas9/3xsgRNAs plasmid were co-transfected at 7:1 
ratio into the previously derived PV-GFP (Described in section 3.2.2). 24 hours after 
nucleofection G418 (analogue of neomycin) was applied to nucleofected cultures at a 
100 µg/mL. The concentration of G418 was gradually increased to 200 µg/mL by day 3 
post- nucleofection.  Five days after nucleofection, the cultures were dissociated and re-
plated as single cell solution at 1x104 or 4x104 cells/ per well onto a 6 cm plate. The 
antibiotic treatment continued and around one week after plating colonies emerged. At 
a size of around 100 cells/colony, colonies were picked and screened for homologous 
recombination by genomic PCR.  
 
The wildtype allele is predicted a 650 bp band using the forward primer 
(O5’_HA_LHX6_F) located upstream the 5’homology arm and the reverse primer 
(3’HA_LHX6_R) located within the 3’UTR of LHX6, whereas if homologous recombination 
event occurred at the 5’ end, I would expect to see a 765 bp amplicon from PCR using 
the same 5’forward primer and the reverse primer (mCherry_R) within the mCherry 
sequence (See Figure 3.2A for primers localisation). Following a similar PCR screening 
design, 3’homologus recombination was assayed by the amplification of a 963 bp PCR 
product  by using a forward primer located within the resistant cassette (Neo_F) and a 
reverse primer located outside the 3’homology arm (SA_LHX6_R).  
 
The 5’ targeted band (765 bp) was produced by 4 out 37 clones (Figure 3.2C). Two of 
which (clone 4 and 7), did not amplify the wild type PCR product (Figure 3.2B), suggesting 
that targeting occurred in both alleles of LHX6. 3’ homologous recombination was 
verified only in the clones that underwent targeting at the 5’ end, all of the 4 clones 
produced the predicted 963 bp mutant band (Figure 3.2D). Homologous recombination 
of these four hPSCs clones was further verified by DNA sequencing of the 5’ PCR 
amplicon which confirmed in frame insertion of p2A and mcherry downstream of the 
last LHX6-coding codon (Figure 3.2E).  
During a pilot interneuron differentiation of the derived LHX6 reporter line, I did not 
detect mCherry signal either by flow cytometry or by fluorescence microscopy at day 
45. I therefore removed the floxed neomycin resistance cassette by transient Cre 
47 
 
recombinase expression followed by clonal isolation and expansion (Figure 3.2A).  In 
order to identify clones, which lost the resistance gene, primers flanking the neomycin 
cassette were designed. These primers give rise to a 1.9 kb amplicon when the selection 
gene (Neo) is present or a 276 bp product if removed (Figure 3.2F). Clones identified 
with the small product were further assayed for neomycin sensitivity. The vast majority 
of the cells in cultures died after 2 days exposure to neomycin (Figure 3.2G).  
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Figure 3.2| LHX6-mcherry hPSC line generation. A) For targeting LHX6 locus, 3 gRNAs (sequence 
in magenta) were designed to direct Cas9 to the cutting site. DNA repair by homologous 
recombination was promoted by co-transfection of a targeting vector along the plasmid Cas9/3x 
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sgRNAs.  The targeting vector is flanked by homology arms at the 5’ and 3’ end respectively, 
which correspond to the genomic sequence of LHX6 500 bp upstream (Sequence in green) and 
500 bp downstream of the cutting site (Sequence in red). Between the homology arms, the 
targeting vector encodes mCherry and a resistance cassette for selection of targeted clones. B) 
Gel is showing the PCR to detect the WT LHX6-allele (650). B) Gel is displaying the 765 PCR 
product to detect the targeted allele in the 5’ end by using a forward oligo outside of 5’ 
homology arm with a reverse oligo inside of mcherry sequence. C) Gel showing the 963 bp 
amplicon produced by the targeted allele in the 3’ side using the oligos  Neo_F and SA_LHX6_R  
D) Sequencing verification of 5’targeted-PCR amplicon. PCR products from positive clones were 
purified and sequenced. Downstream of LHX6 last coding codon, p2A and mcherry was 
integrated in frame in the locus.  F) PCR base genotyping after CRE recombinase transfection to 
remove the resistance cassette. A large product (1.9 kb) is amplified from genomic DNA of the 
cell line before CRE recombinase transfection in contrast to the small product (276 pb) amplified 
from clones after CRE transfection. G) After removing the neomycin resistant gene, cultures 
from selected clones where exposed to 150µg/ml G418 to confirm their sensitivity to neomycin. 
Virtually all cells in the culture were dead after 48 h of exposure to G418. 
 
 
 
 
3.2.2 Targeting the PV locus 
This part of the work was initiated by a former member of the laboratory and Dr. Lucia 
Cardo and was carried out prior to LHX6-mCherry targeting. I performed the PCR 
genotyping of the PV targeting, the cloning of PCR products for sequencing and transient 
expression of FLP recombinase to remove the selection gene followed by the clonal 
isolation and phenotype verification of the selection gene removal. Since LHX6 targeting 
was 100% my work from design to execution I decided to present the LHX6 part first and 
in greater detail.   
 
3.2.2.1   PV-targeting design  
The PV a targeting vector was designed and constructed by a former member of the 
laboratory Dr. Xinsheng Nan. An eGFP reporter was employed and was placed 
downstream of an IRES sequence. IRES provides a binding site for the 40S ribosomal 
subunit (Chan et al., 2011), for this reason the stop codon of PV is included in  the5’ 
homology arm of the targeting vector, as depicted in Figure 3.3A. The Ires-eGFP is 
followed by a FRT flanked antibiotic resistance cassette (CMV-HygTK-SV40pA).  These 
sequences were inserted between the 5’ and 3’ homology arms, which correspond to 
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the PV gene encompassing 700 bp upstream and 500 bp downstream of the Cas9 cut-
site (Figure 3.3A).   
To minimise any impact in the expression of the target gene, one sgRNA was designed 
to target the exon 5 of human PV gene encompassing the stop codon. Employing the 
Cas9 expression plasmid from the multiplex CRISPR/Cas9 assembly system kit (Sakuma 
et al., 2014), the sgRNA was cloned into  the human optimized Cas9 expression plasmid. 
The resulting plasmid is named Cas9/1xsgRNA  
 
3.2.2.2  PV-GFP cell line derivation 
The Cas9/1xsgRNA plasmid was co-electroporated with the PV-targeting vector into the 
H7 cell line. Both plasmids were delivered as circular plasmids in a ratio of 1 µg 
Cas9/1xsgRNA: 3 µg PV-targeting vector. Individual hygromycin resistant clones were 
isolated, expanded and screened for homologous recombination.  
Genotyping was firstly carried out by PCR amplification using a forward primer upstream 
of the 5’homology arm and a reverse primer in hygromycin-TK resistance cassette, 4 out 
40 clones gave rise to the expected PCR product for successful targeting (1.6 kb, Figure 
3.3B). All four clones were heterozygous as the WT PCR product was also detected (617 
bp, Figure 3.3C).  Homologous recombination was further confirmed by DNA sequencing 
of the PCR amplicon (Figure 3.3D). Due to the length of the amplicon, partial sequencing 
results are shown. The upper panel shows a portion of the 5’HA while the lower panel 
displays partial CMV promoter sequence. 
Once targeted gfp integration into the PV locus was validated, an expression plasmid 
encoding FLP recombinase (Figure 3.3A) was transfected to remove the CMV-HygroTK-
SV40pA cassette upstream of iresGFP. 
The excision of the antibiotic resistance cassette should allow the transcription of GFP 
in PV+ cortical interneurons. Ganciclovir was used for enriching cells that lost the TK gene 
(Thymidine Kinase), as in the presence of TK, ganciclovir would be phosphorylated; 
interfering with DNA replication  resulting in cell toxicity, and hence, clones in which the 
selection cassette was excised became resistant to ganciclovir (Figure 3.3E).   
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 Individual clones resistant to ganciclovir were isolated expanded and assayed for 
sensitivity to hygromycin. The majority of cells died after 6 days exposure to hygromycin 
(Figure 3.3E).   Clones displaying resistance to ganciclovir and sensitivity to hygromycin 
were expanded and one of them was selected for a second round of targeting in the 
LHX6 locus as described in section 3.2.1.  
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Figure 3.3| PV-gfp hPSC line generation. A) For targeting PV locus, a gRNA (sequence in 
magenta) was designed to direct Cas9 to the cut site in the exon 5 of PV. A targeting vector was 
co-transfected along with Cas9/1xsgRNA to promote DNA repair by homologous recombination.  
The targeting vector contains GFP coding sequence and a positive/negative dual selection 
cassette (CMVp-HygTK-SV40pA) flanked by homology arms, which correspond to the genomic 
sequence of PV. Sequence upstream of the Cas9 cutting correspond to the 5’HA (sequence in 
red) and sequence downstream is the3’HA (sequence in green. B) PCR based genotyping using a 
pair of primers flanking the 5’ homology arm. PCR product (1.6 kb) was obtained from 10% of 
clones screened. C) Targeted clones are heterozygous as they gave rise to the PCR product to 
detect the WT allele. D) Partial sequences from the PCR product to detect the targeted allele 
showing a portion of the 5’HA and the CMV promoter integration. E) Isolated clones after FLP 
recombinase transfection were resistant to ganciclovir, and sensitive to hygromycin showing 
loss of the resistance cassette. 
 
 
 
 
3.3  Discussion 
In this chapter I successfully generated a dual reporter hPSC line (LHX6-mcherry/PV-
GFP), by targeted insertion of a mcherry and GFP reporter to the LHX6 and PV locus, 
respectively. The LHX6-mCherry reporter is designed to identify MGE-derived GABAergic 
cortical interneurons (derived from the MGE) (Liodis et al., 2007). The LHX6-
mcherry/PVAL-gfp dual reporter line is expected to be a highly valuable tool for studying 
different aspects of the development and function of interneurons in health and 
diseases as cortical interneuron dysfunction has been implicated in the aetiology of 
NDDs (Coghlan et al., 2012; Wohr et al., 2015).  
A NKX2.1-GFP hPSCs reporter has previously been developed with the aim of tracing the 
development of forebrain derivatives (Goulburn et al., 2011; Maroof et al., 2013).   
However the GFP+ neural progenitors derived from this reporter are not necessarily 
committed to GABAergic cortical interneurons due to the role of Nkx2.1 on cholinergic 
development (Lopes et al., 2012; Sandberg et al., 2016; Sussel et al., 1999). Moreover 
Nkx2.1 expression pattern suggest that in an advanced state of differentiation Nkx2.1 is 
indeed labelling striatal interneurons (Nobrega-Pereira et al., 2008; Sussel et al., 1999). 
In contrast, LHX6 expression is restricted to nascent cortical interneurons and its 
expression remains in these cells in their mature state (Du et al., 2008; Sandberg et al., 
2016).  Despite the accumulated literature suggesting that LHX6 might provide a better 
labelling for cortical interneurons, a detailed characterization of the specificity and 
expression profile of mCherry signal in progenitors and interneurons derived from the 
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LHX6-mCherry hPSCs is necessary in order to address whether the targeting of LHX6 is a 
better strategy than NKX2.1-GFP for tracking cortical interneurons. It is also necessary 
to demonstrate the faithful labelling of  MGE-derived interneurons as it has been 
reported that even when a reporter is  driven by  endogenous regulatory elements of  
targeted genes, the labelling of other populations may occur (Hu et al., 2013). 
Although it is predicted that the LHX6-mcherry reporter will label the majority of MGE-
derived interneurons, the identification of specific interneuron subtypes would require 
another marker or reporter (e. g. by targeting PV and SST genes).  Unlike the vGAT-
mCherry reporter published to date, which labels all GABAergic neurons (DeRosa et al., 
2015), the hPSCs dual reporter described in this thesis was designed to specifically mark 
the PV subtype. Since PV and SST are the two major interneuron subtypes originated in 
the MGE, the reporter cell derived mCherry+-GFP+ would be the PV subtype, while the 
mCherry+_GFP- mature neurons would likely be the SST+ subtype. However, since the 
expression of cortical interneuron subtype markers occurs late during foetal 
development (PV mRNA increases after 200 days of development whereas SST increases 
after 100 days, reported in the human brain transcriptome database 
(http://hbatlas.org/), and that hPSC-derived neurons are often immature, 
mCherry+_GFP- phenotype in vitro may represent immature MGE derived interneurons.   
In contrast to classic strategies of homologous recombination, which required the use 
of longer homologous arms (beyond 1.5 kb) (Zwaka and Thomson, 2003),  the use of 
CRISPR/cas9  technology in this work  allowed the efficient  targeting with homologous 
arms as short as 500 bp and 700 bp  in two independent loci in hESCs.  This is in line with 
published reports suggesting that short homology arms of 500-1000 bp in length are 
sufficient for CRISPR/Cas9 assisted gene targeting (Merkle et al., 2015; Zhu et al., 2015).  
Moreover, unlike traditional gene targeting method, which requires the delivery of up 
to 40 ug of targeting vector (Zwaka and Thomson, 2003); the CRISPR/Cas9 strategy in 
combination with modern methods of DNA delivery, such as nucleofection,  allowed the 
use  of smaller quantities of DNA (1-2 ug of Cas9/sgRNA along with 6-7 ug of targeting 
vector ) delivered as circular plasmids. Additional advantages of the selected methods 
for deriving the dual reporter line was the possibility of using more than one sgRNA to 
target a locus. In this thesis, 3 sgRNAs were used for LHX6 targeting which lead to the 
generation of two homozygous clones, while one sgRNA was used in the case of PV locus 
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where all the targeted clones were heterozygous. Although targeting efficiency can be 
loci dependent, this result suggests that multiple gRNAs increases gene editing 
efficiency. This finding agrees with a previous study by Kabadi, et al.  2014; in which a 
higher level of target gene activation was achieved when multiple gRNAs were employed 
for targeting the promoter of a gene of interest in a CRISPR activator system (Black et 
al., 2016; Kabadi et al., 2014).  
Regarding the functionality of the dual reporter, when designing the LHX6 targeting 
vector the drug selection gene was placed downstream of mCherry sequence (Figure 
3.2A). This design allows mCherry to be expressed without the need to remove the 
selection cassette. However, I did not detect mCherry expression at day 45 of 
differentiation a stage when LHX6 is known to be expressed (Maroof et al., 2013). We 
postulated that the lack of mCherry signal may be due to interference by the neomycin 
resistance gene. Inhibition of the reporter expression by the drug selection unit, even 
when it is placed downstream of the reporter gene has also been recently observed in 
the derivation of an OCT4-GFP hPSCs reporter (Zhu et al., 2015).  Interestingly, the 
opposite effect (increased intensity of fluorescence) as an effect of a retained selection 
cassette in a knock in mouse has also been documented (Scarff et al., 2003). In addition 
to above reports, several studies have suggested a potential interaction between the 
resistance cassette (specifically the PGK-neo) and the regulatory elements of the 
targeted gene (Pham et al., 1996; Scacheri et al., 2001). It has also been suggested that 
such interaction may vary a lot in different loci (Pham et al., 1996). Thus, the removal of 
the selection element is advisable as the effect of the retained selection unit is 
unpredictable. These reports, together with the absence of the LHX6-mcherry reporter 
signal prior to the excision of the selection cassette in my study, suggest that the 
removal of the selection cassette may be a necessary manipulation in order to visualise 
the expression of the reporter gene. Further functional characterization of the dual 
reporter will be presented in Chapter 4.  
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4. Faithful expression of the mCherry reporter during differentiation 
of hPSCs towards the MGE fate  
 
 
4.1 Introduction 
In contrast to transgenic integration of exogenous promoters, reporter cell lines 
generated by knock in approach offer advantages for containing all the required 
components of the endogenous gene regulatory units, such as promoters and 
enhancers. Thus, expression of the knock in reporters are more likely to faithfully mirror 
the dynamic transcription of the targeted gene (Rojas-Fernandez et al., 2015).  Indeed, 
published data demonstrates that the fluorescent protein reporters in the existing hPSCs 
knock in lines exhibit expected expression patterns appropriate to the state of 
differentiation and the targeted gene, and are co-expressed with the protein produced 
by the target genes (Li et al., 2015b; Zhu et al., 2015). Combining the multi-lineage 
differentiation potential of hPSCs, cell type specific reporter lines serve as a powerful 
tool for investigations concerning cell fate decisions at molecular, cellular and 
physiological levels.  
The success of using hPSC reporters relies on the full preservation of pluripotency and 
differentiation potential by these cells. Another key requirement is the faithful 
expression of the reporter to that of the targeted gene. From the plethora of 
accumulated knowledge from mouse models, it is known that Lhx6 is expressed in the 
MGE from E11.5 and is mostly localised in the sub-ventricular and sub-mantle zones of 
the MGE, marking post-mitotic neurons and potentially progenitors leaving the cell cycle 
(Grigoriou et al., 1998; Liodis et al., 2007).  As mouse embryonic development proceeds, 
the expression of Lhx6 is further restricted to and preferentially expressed in PV and SST 
interneurons. Therefore, it is important to ascertain that the LHX6-mCherry reporter 
expression mirror the above pattern during MGE differentiation in vitro. This can be 
achieved by the combined use of small molecules and growth factors mimicking mouse 
forebrain development and instructs the cells towards the MGE-like fate, activating 
NKX2.1 expression that in turns activate LHX6 expression (Du et al., 2008; Maroof et al., 
2013; Noakes et al., 2019), thus providing a cell population to assay mCherry expression 
pattern and fidelity. 
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One of the main applications of the LHX6-mcherry hPSCs reporter lines is to develop an 
improved interneuron differentiation protocol. In terms of interneuron differentiation, 
currently most of the published protocols successfully generate a large proportion of 
NKX2.1+ cells, reflecting efficient acquisition of an MGE-like identity.  
These NKX2.1+ cells can be further differentiate into GABA+ cells. However, as 
summarised in Sun et al. 2016, these protocols produce low percentages of SST+ (1.53 % 
of total cells) and even lower percentages of PV+ interneurons (less than 1% of total 
cells), although a pre-sorting step of NKX2.1+  MGE progenitors could increase the yield 
(Maroof et al., 2013; Nicholas et al., 2013; Sun et al., 2016).  The low yield of MGE-
derived interneuron subtypes has been partially attributed due to the long timeline 
required for interneuron maturation (Nicholas et al., 2013).  Higher yield of  PV+ has 
been  reported in mice by  direct reprogramming, but  the PV+ phenotype was not stable 
(Colasante et al., 2015). Therefore, further research is need to promote efficient in vitro 
generation of defined interneuron subtypes.  
The complexity of the developmental mechanisms governing interneuron diversity 
makes  challenging to develop improved differentiation paradigms. As the 
differentiation protocols seek to mimic the embryonic development of the MGE-derived 
interneurons, the optimisation of the differentiation protocols needs to take into 
account the intricate interaction of cell intrinsic control and environmental influences as 
well as temporal sequence of these regulatory mechanisms. Hence, a detailed 
understanding of the developmental trajectories of the interneuron subtypes will inform 
on the cues and timing required by hPSCs during in vitro differentiation.  
The recent development of single cell RNA-seq technologies have uncovered exciting 
new information on such developmental mechanisms. This new technology allows the 
delineation of genes expressed at different phases of development of the MGE 
subpopulations, presumably fated to become SST+ or PV+ interneuron subtypes (Mayer 
et al., 2018; Mi et al., 2018). However, once these genes are identified, their functional 
role during interneuron differentiation and maturation must be tested in order to design 
new differentiation protocols that allow the generation of interneuron populations with 
mature phenotypes that serve as disease models, drug screening and regenerative 
medicine applications. Therefore, the generation and validation of hPSC reporters to 
track MGE-like cells fated to become interneurons is essential.  
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In this chapter, I present an extensive characterization of the LHX6-mcherry reporter 
and provide evidence of its potential as a screening platform for functionally identifying 
factors capable of regulating interneuron specification and maturation. However, I was 
unable to validate GFP expression in PV+ neurons due to the very low yield of PV+ cells 
under our differentiation protocol. Therefore, the dual reporter will be referred as LHX6-
mCherry reporter thereafter in this thesis.  
 
 
4.2  Results  
4.2.1 The key features of hPSCs are preserved in  LHX6-mCherry reporter 
cells 
To start the characterization of the LHX6-mCherry reporter cells, the expression of the 
pluripotency marker OCT4 was verified by immunostaining. As shown in Figure 4.1A, 
under self-renewal conditions, the vast majority of cells were stained positive for OCT4. 
The colony morphology appeared flat and compact, which is typical for human 
pluripotent cells (Figure 4.1B). Karyotyping revealed that 82% of cells contained 46 
chromosomes, the normal number for somatic human cells (Figure 4.1C). However, this 
analysis was restricted to preparing chromosomes for counting, following the procedure 
detailed in section 2.3.4.  Therefore, genomic DNA was extracted from the dual reporter 
cell line and the H7 parental line. The core team of the MRC Centre for Neuropsychiatric 
Genetics and Genomic performed a CNV (copy number variation) analysis. The dual 
reporter displays two CNVs also found in the parental H7 cell line (a deletion in the 
2q37.3 and a duplication in the 3q26.1), hence, these CNVs were not generated during 
the two rounds of targeting. Furthermore, the duplication in region 3(q26.33q27.2) has 
been found in advances passages of hESCs (Spits et al., 2008). Because of the close 
proximity with the duplication found in both the dual reporter and the parental line, it 
is possible that this duplication was caused by long-term culture.  With regard to the 
deletion in 2q37.3, this has not been reported within the common abnormalities found 
in hESCs, the closest abnormality to this locus was a deletion  in the position 2(q24q33), 
which was reported as a non-recurrent abnormalities found in hESCs (Taapken et al., 
2011). Another CNV in locus 17p13.1 (deletion) was detected in the LHX6-mCherry/PV-
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GFP, unlike the previous CNVs, this was not present in the parental cell line. After an 
extensive search, I could not find this CVN reported as common or rare CNVs previously 
identified in hESCs and further investigation will be necessary to address to which extent 
this CNV may affect the properties of the the LHX6-mCherry/PV-GFP reporter. The above 
results demonstrates that most of the key properties of PSCs were maintained following 
two rounds of gene editing. 
The LHX6-mCherry cells where then induced to differentiate towards MGE-like fate, 
following a protocol modified from Maroof et al., 2013 (described in Noakes et al., 2019) 
(Figure 4.1D). Small molecule based dual SMAD inhibition was used to promote 
neuralisation. In this protocol, dual SMAD inhibition was performed by the combined 
action of   LDN-193189 and SB-431542. WNT signalling inhibition was promoted with 
XAV939 to facilitate the acquisition of anterior/ventral fate. The cells were further 
ventralised by exposure to SHH and purmorphamine which is a SHH agonist (Maroof et 
al., 2013).  In order to assay whether the gene editing process had any impact on the 
differentiation potential of the LHX6-mCherry reporter cells were differentiated 
alongside the H7 parental cells. It was found that at day 21 of differentiation, the major 
population of the culture expressed FOXG1, a key transcription factor important for 
telencephalon development and is considered a bona fide marker for telencephalon 
(Aguiar et al., 2014). At this stage, MGE markers such as NKX2.1, and OLIG2 were also 
detected at abundance (Figure 4.1E). 
Counting the number of immune-reactive cells for telencephalic and MGE markers 
revealed  similar percentages of  cells positive for NKX2.1 (H7: 90.13±2.07, LHX6-
mCherry: 88.26±2.80), OLIG2 (H7: 13.18±1.16, LHX6-mCherry: 12.66±1.06) and FOXG1 
(H7: 72.32±2.98, LHX6-mCherry: 80.64.26±3.98)  (Figure 4.1F); suggesting that 
differentiation potential was not affected after two rounds of gene targeting.  
The above progenitors were further differentiated until day 65. At this stage, cells 
expressing   MGE-derived neuronal markers, such as GAD67 and SST were found in the 
cultures (Figure 4.1G). However, no PV+ cells were detected by immnunocytochemistry 
(Figure 4.2 A). A RT-PCR for detecting PV transcript was also performed, the transcript 
was barely upregulated  along differentiation (Figure 4.2 B).  I therefore concluded that 
PV cells were not present in those cultures by day 65 of differentiation.  Furthermore, 
no GFP signal was observed in lived cells by fluorescent microscopy. Taking these results 
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together, I concluded that the lack of PV cells rather than the dysfunctionality of the GFP 
reporter was the cause of the absence of GFP signal.  Although these results were 
obtained from two independent sets of differentiation, it is possible that the evaluation 
of PV+ cells production and PV-GFP functionality will need the analysis of several 
differentiations and longer timeframe. This because it is known that the generation of 
PV+ cells using our differentiation paradigm is not robust, as PV+ neurons were detected 
in 50% of independent differentiations (Noakes et al., 2019).  
In addition the timeline of PV+ interneurons development is extended to postnatal 
stages in mouse (Mukhopadhyay et al., 2009), while the in vitro differentiation of hPSCs 
towards cortical interneurons resembles the extended timeline of cortical interneuron 
development in human (Nicholas et al., 2013). This highlights the need for extending the 
timeline of the analysis. Moreover, future validation of the PV-GFP reporter will require 
the use of a positive control each time that PV is assayed by immunostaining. In my 
experiments, the used PV antibody has proven to detect PV interneurons in other 
experiments; however, as change of experimental conditions may affect antibody 
performance, the use of a positive control is necessary to accurately determine whether 
PV is present or absent in the analysed cultures.    
Interestingly numerous CR+ cells (Figure 4.1G), a lineage mostly originated from the CGE 
(Kelsom and Lu, 2013), were identified. Although a small proportion of CR+ interneurons 
that co-expressing SST are derived from the dorsal MGE (Fogarty et al., 2007), double 
staining for CR and SST detected few double positive interneurons.  The lack of PV+ cells 
has prohibited the functional validation of the PV-GFP reporter function. This highlights 
the need for a better understanding of interneuron subtype specification that would 
facilitate the design of efficient differentiation paradigms for defined interneuron 
subtypes.   
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Figure 4.1| LHX6-mcherry/PV-gfp dual reporter cell line acquires MGE-like fate upon 
differentiation. A) The dual reporter cell line expresses the transcription factor OCT4 as a marker 
of pluripotency after two rounds of gene targeting, virtually all the cells in the culture are 
positive for OCT4 (red) assayed by immunocytochemistry. B) The colony morphology of the dual 
reporter cell line is characteristic of hPSCs. C) 82% of cells contains normal number of 
chromosomes. D) Diagram of the differentiation protocol to induce MGE-like fate. The diagram 
depicts media, factors, and substrate and time point of each stage of the differentiation. E) Upon 
differentiation, the dual reporter cell line is committed to a MGE-like fate, expressing distinctive 
transcription factors of MGE as NKX2.1 (green) and OLIG2 (red), >70% of cells is also expressing 
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FOXG1 showing their anterior character.  F) Quantification of the percentage of MGE markers in 
the cultures, showing that the dual reporter cell line owns a comparable capability to the 
parental line H7 to acquire MGE-like fate. Bar graphs shows mean ± SEM. No statistical 
difference between the parental line H7 and the dual reporter cell line. (H7: n=9,  dual reporter: 
n=9, P>0.05, 2-tailed t-test). G) After allowing maturation of the MGE-like cells, they acquire 
fates of MGE derivatives, such as calretinin (green), SST (green) and GAD67 (magenta). Scale Bar: 
A and B 20 µm, C 50 µm, E and G 250 µm. 
 
 
Figure 4.2| No PV+ cells were detected by day 65 of the dual reporter differentiation. A) 
Immunocytochemistry for detecting PV+ cells (green). No   PV+ cells were detected in spite that 
many cells were already NeuN+ (red or magenta).  B) Expression profile of PV along MGE 
differentiation. PV transcript was downregulated with respect to ESCs and it was not 
upregulated by day 60 of differentiation.  Bar graphs shows mean ± SEM (n=2). 
 
 
4.2.2 Kinetic of mCherry+ cell population mirrors the expression pattern of 
LHX6 during MGE differentiation  
LHX6 is known to be expressed in immature interneurons once MGE progenitors leaving 
the cell cycle and it is necessary for the development of SST and PV cortical interneurons 
(Du et al., 2008; Liodis et al., 2007). I therefore examined the generation of mCherry+ 
cells during MGE differentiation, and their co-expression with LHX6.  Firstly, I 
characterised the dynamics of LHX6 transcript expression by qPCR during MGE 
differentiation protocol. I found that, although upregulated upon differentiation, LHX6 
transcription level was not remarkably increased, as its maximum fold change was 
23.83±9.48 (4.3A). Secondly, I monitored the presence of   mCherry+ cells by flow 
cytometry, as well as by direct inspection under the fluorescence microscope. Flow 
cytometry detected mCherry+ cells from day 20 and the number gradually increased to 
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its peak at day 35 (21.71 ± 1.82%, Figure 4.3B). According to studies in mice, LHX6 
expression is maintained in mature neurons (Liodis et al., 2007), however, the 
percentage of mCherry+ cells decrease after day 35.   
The above observation was unexpected. Given that mCherry+ cells are post-mitotic, the 
observed decrease in proportion of these cells could be due to the proliferation of 
mCherry- cells, which could contain precursors of mCherry+ cells as well as those 
destined to other fates.  To investigate whether such decrease was due to a diluting 
effect of the mCherry+ population by the proliferative mCherry- cells, I treated the 
differentiation cultures with demecolcine, an inhibitor of microtubules polymerization, 
which prevents cell division through destabilization of the microtubule attachment to 
spindle poles (Yang et al., 2010).  
Cultures were treated with 1µg/mL of demecolcine for 2 hours on day 35 of 
differentiation and the percentage of mCherry+ cells was assayed by flow cytometry at 
days 40, 45, 50 and 60 (Figure 4.3C). I found that, instead of decreasing in number as  in 
untreated cultures after day 35, the number of mCherry+ cells in demecolcine treated 
cultures increased to its highest level of 38.92 ± 1.95% at day 40. The proportion of 
mCherry+ cells dropped slightly to 31.5 ± 1.0% at day 45 and to 28.6 ± 0.9% at day 60 
(the latest time point analysed). These results suggest that the decrease of mCherry+ 
population observed previously was most likely due to expansion of mCherry- cells 
rather than a dramatic loss of mCherry+ cells at the later phase of differentiation. The 
temporal profile of mCherry+ cells under such condition mirrors the expression pattern 
expected for LHX6 during MGE development, which start in nascent MGE-derived 
neurons and maintained in cortical interneurons throughout life. However, few 
mCherry+ cells were readily detectable by direct observation of the cultures under the 
fluorescent   microscope (Figure 4.3D).  
I then investigated whether mCherry+ expression faithfully mirrors that of LHX6 protein 
by double immunostaining for mCherry and LHX6. Firstly I evaluated the specificity of 
the mCherry and LHX6 antibodies in  medium spiny neuron (MSN) progenitors,  a LGE-
derived fate that lacks LHX6 expression (Fjodorova et al., 2015). MSN were derived from 
a line of hPSCs constitutively expressing mCherry (kindly provided by a fellow PhD 
student Francesca Keefe). Immunostaining of MSN progenitors did not show LHX6+ cells 
whereas mCherry signal was evident (Figure 4.3E). A second set of negative control was 
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the undifferentiated parental H7 cells alongside the LHX6-mCherry reporter. All cells 
appeared LHX6+, however a weak staining of mCherry was found only in the LHX6-
mCherry hPSCs (Figure 4.3F). Then I proceeded to evaluate the co-localisation of 
mCherry and LHX6 in MGE-like progenitors,   I found that 97.9 ± 0.46 %  of   LHX6+ cells 
were mCherry+, while 97.56 ± 1.10 %  of  the mCherry+ cells were LHX6+ (Figure 4.3G). 
This result suggests that the mCherry reporter faithfully marks the LHX6+ cells.  
However, immunostaining detected many more mCherry+ than those by flow cytometry. 
17.27± 1.67% mCherry+ cells were detected at day 40 by flow cytometry whereas 
89.48±2.76% mCherry+ cells were detected at day 41 by immunocytochemistry. This 
inconsistence might be a consequence of the low levels of LHX6 expression during MGE 
differentiation as previously found by qPCR (Figure 4.3A). It is possible that such low 
levels of LHX6-mCherry transcription give rise to boarder line levels of mCherry protein 
for the sensitivity of flow cytometry (Figure 4.3B,C), and a level too low for the naked 
eye to detect under the microscope (Figure 4.3D). However, as the antibody amplifies 
the signal of LHX6 and mCherry during immunostaining thus higher percentages of 
mCherry+/LHX6+ cells were found by this method.  
Overall, the results presented in this section show that mCherry reporter accurately 
labels LHX6+ cells. The temporal kinetic of the mCherry+ population during 
differentiation was consistent with the expected pattern for LHX6 expression in post-
mitotic cortical interneurons in vivo (Figure 4.3C) and indeed mirror that of LHX6 
transcript profile detected by qPCR (Figure 4.3A).  
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Figure 4.3| LHX6-mcherry/PV-gfp dual reporter cell line labels the LHX6+ population. A) 
Expression profile of LHX6 along MGE differentiation. This data shows a maximum fold change 
of LHX6 transcript during the differentiation of the dual reporter was 23.84±9.48 (mean±SEM 
n=2), whereas the maximum fold change of LHX6 transcript in H7 cells was 66.55±11.38 (Figure 
5.5B). Therefore, the levels of expression of LHX6 in the dual reporter is decreased by around 
the half in comparison to the parental cell line. Assaying the effectiveness of the multicistronic 
expression in the reporter might explain the difference in the LHX6 expression levels. B) Kinetic 
of the mCherry+ population along MGE in vitro differentiation. The dual reporter cell line peaks 
at 21.71 ± 1.82% at day 35 whereas H7 cell line maintains a percentage < 2% at each time point, 
likely due to auto-fluorescence (Data is presented as mean ± SEM, n=6). C) Comparison of the 
kinetic of mCherry+ population when treated with and without mitotic inhibitor (yellow and 
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orange line respectively). As in panel B, not treatment with mitotic inhibitor leads to a decrease 
in the percentage of the mCherry+ population after peaked at day 35. Treatment with 
demecolcine shifts the kinetic of mCherry+ cells, as it peaks at day 40 and the percentage remains 
stable from day 45 onwards. Suggesting that decrease in mCherry+ populations is a consequence 
of dilution of proliferative mCherry- cells (Data is presented as mean ± SEM, n=3). D) mCherry 
expression observed by fluorescence microscopy in live cells. E, F) Antibodies for detecting LHX6 
and mCherry are specificity as no signal for LHX6 is detected in MSN progenitors. LHX6 was 
detected in the pluripotent stage with a week co-expression of mCherry only in the reporter cell 
line. G) Immunocytochemistry showing co-expression of mCherry (green) with LHX6 (red) in 
MGE progenitors derived from the LHX6-mCherry reporter. Virtually all cell expressing mCherry 
are expressing LHX6 (merge mCherry/LHX6, yellow). D and G Scale bar 20µm. E and F scale bar 
250 µm. 
 
 
4.2.3 mCherry  expression is restricted to the MGE-like cells  
Another aspect to consider regarding the LHX6-mcherry reporter characterisation 
concerns regional specificity. To assess whether mCherry expression is restricted to cells 
of the MGE-fate, the LHX6-mCherry cells were induced to differentiate towards the 
cortical-fate, with the MGE differentiation as the positive control.  
The generation of cortical cells was achieved by culturing cells in basal N2B27 medium 
following the dual Smad inhibition step (ie. the control condition as described in Arber 
et al., 2015) . To corroborate that the cells acquired the expected fate as designed by 
the protocol, cortical and MGE markers were assayed by immunocytochemistry. Both 
the cortical and MGE cells should express the pan-forebrain marker FOXG1 (Aguiar et 
al., 2014), while only cortical-like progenitors express PAX6, a transcription factor that 
is expressed in the radial glia of dorsal mouse telencephalon (Ypsilanti and Rubenstein, 
2016) (Figure 4.4B, D). As expected, NKX2.1+ and OLIG2+ cells were absent in the 
cortically differentiated cultures (Figure 4.4B, right column and Figure 4.4C). 
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Figure 4.4| The reporter cell line displays the correct set of MGE or cortical makers. A) 
Comparison of the small molecules and growth factors employed to induce MGE and cortical 
fate. B) The H7 parental line and the dual reporter cell line induced to differentiate towards MGE 
fate give rise to FOXG1+, NKX2.1+, OLIG2+ , PAX6- cell population, whereas the dual reported cell 
line induced to differentiate  as cortical progenitors were FOXG1+, NKX2.1-, OLIG2-, PAX6+ cell 
population. C) Percentage of positive cells for  MGE makers in H7 and LHX6-mCherry found in 
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cells differentiated through MGE and cortical-differentiation paradigms. (Data is presented as 
mean±SEM, n=3)   D) Percentage of positive cells for forebrain and dorsal markers in cell 
populations obtained through MGE and cortical protocols. (Data is presented as mean±SEM, 
n=3). B scale bar 250 µm. 
 
 
 
In contrast, NKX2.1+- OLIG2+- PAX6- cells were found in MGE cultures (Figure 4.4B left 
and middle column and Figures 4.4C, D).   During human embryonic development, PAX6 
is found in the CGE and LGE on the 15 gestation week but is absent in the human MGE 
(Mo and Zecevic, 2008). The absence of PAX6 in MGE-like cultures validated the 
robustness of the MGE differentiation paradigm, which was further confirmed with the 
quantitative outcome of the assayed markers in my cultures (Figure 4.4 C and D).  
Lhx6 is known to be expressed in the ventral telencephalon but absent in the dorsal 
mouse developing forebrain (Grigoriou et al., 1998; Liodis et al., 2007). Additionally, 
there is evidence that LHX6 expression is absent during human cortical development 
(http://cortecon.neuralsci.org/). Therefore, mCherry signal is predicted to be uniquely 
detected in cells differentiated through the MGE protocol whilst absent in cortical 
differentiation.  
By flow cytometry analysis, I found that mCherry signal was indeed absent in cortical 
cultures at day 25, 35 and 45, while detected in the MGE cultures at the 3 time points 
analysed (Figure 4.5A). Moreover, immunocytochemistry analysis of day 65 in cortical 
cultures confirmed the absence of SST+ cells (Figure 4.5B), while this cell type was 
evident in MGE cultures as predicted (Figure 4.5B), importantly these SST+ cells were 
mCherry+ (Figure 4.5C). The findings described in this section, demonstrates that 
mCherry signal, reporting LHX6 expression, is absent in other forebrain fates, thus 
mCherry expression is a reliable readout to assay culture conditions for the in vitro 
induction of MGE-like fate and its derivatives. 
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Figure 4.5| mCherry signal is a reliable readout of culture conditions to obtain MGE-derivatives. 
A) Flow cytometry at different time points along differentiation shows that mCherry signal is 
only detected during MGE differentiation, whilst mCherry fluorescence in cortical progenitors is 
comparable to the negative control (H7 parental cell line).  B) Maturation  of MGE-like 
population gave rise to SST+ and CR+ cells, whereas cortical-like progenitors matured as CR+ but 
no SST+ cells were found Conversely makers or cortical layers were absent in MGE-like mature 
cells  and detected in cortical-like mature cells. C) mCherry is co-expressed in SST+ interneurons 
obtained from in vitro MGE differentiation protocol. Thus, a proportion of mCherry+ MGE-like 
progenitors develop as SST+ interneurons. B and C scale bar 250 µm. 
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4.3 Discussion 
In this chapter, the functionality of the LHX6-mCherry reporter cell line was evaluated 
and an extensive characterisation of the reporter cell line showed that, after two rounds 
of gene targeting, the LHX6-mcherry cells behaved similarly to that of the parental line 
in generating MGE-like cells, preserving OCT4 expression and normal number of 
chromosomes (Figure 4.1E, F).  
Different approaches were employed to detect mCherry+ cells, such as flow cytometry, 
immunostaining and direct visualisation of mCherry under the fluorescent microscope. 
From these different analyses, very few mCherry+ cells were found by direct microscopic 
inspection of live cells (Figure 4.3D) and a pronounced difference of around 72.21% in 
the proportion of mCherry+ cells was found by immunostaining and flow cytometry 
evaluated between day 40 and 41. The discrepancy found by distinct methods might be 
a consequence of low levels of upregulation of LHX6 in our differentiation conditions, 
based on the expression profile obtained by qPCR, where the maximum LHX6 fold 
change recorded was 23.83 ± 9.48. This could be hampering the accurate visual 
detection of mCherry+ cells, which, depending on the expression levels could be only 
visualised by immunostaining and/or flow cytometry. Indeed the small fold change of 
LHX6 detected by qPCR correlates with low intensity of fluorescence detected by flow 
cytometry. Low levels of  LHX6 expression during in vitro MGE differentiation has been 
also reported by Nicholas, et al., 2013; that through an embryoid body differentiation 
approach, reported 0.003 fold change (expressed as 2-δCT) of LHX6 expression (Nicholas 
et al., 2013).  
One of the main purposes to generating the LHX6-mcherry reporter is to identify cortical 
interneuron determinants.  Therefore showing restriction of the mCherry signal to the 
MGE-lineage was also essential. My results showed that, mCherry expression is only 
expressed during the differentiation of the MGE lineage but not in pallial derivatives. 
Therefore, mCherry signal could be used as a readout to screen culture conditions 
and/or novel molecules and transcription factors able to induce MGE derivatives 
committed to become cortical interneurons. Even though, it was demonstrated that 
mCherry signal is not detected during pyramidal cortical differentiation, a lineage 
derived from the pallium, which does not express LHX6 (http://cortecon.neuralsci.org/), 
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this experiment do not exclude that mCherry could be inappropriately expressed in 
other lineages. Since differentiation through embryoid bodies promotes the derivation 
of cell types from the three germ layers(Brickman and Serup, 2017), differentiating the 
dual reporter through this approach might help to formally rule out whether mCherry 
could be wrongly expressed in other cell fates. 
Overall, the results presented in this chapter suggest that targeting the LHX6 gene is 
indeed a suitable approach to track MGE derivatives fated to become cortical 
interneurons, nevertheless one of the main limitations of the LHX6-mCherry reporter is 
the low intensity of the mCherry fluoresce along 60 days of MGE differentiation. It is not 
clear whether LHX6 is physiologically low upregulated during MGE embryonic 
development or whether the low levels of LHX6 transcript induced during in vitro 
differentiation paradigms are the consequence of the lack of signals to support a strong 
upregulation of LHX6. In either case, the derivation of a second-generation LHX6-
mCherry reporter may improve the visual detection of LHX6+ cells.  Such a second 
generation of LHX6-mCherry reporter could be done by replacing the mCherry 
fluorescent protein by the emerald GFP, which has almost three times the quantum yield 
(fluorescent photons per absorbed photon) than mCherry, and hence may be  three 
times brighter (Cranfill et al., 2016). 
Another option to derive a second generation LHX6-reporter line is to adapt the genetic 
recombination approach used for lineage tracing in mouse models, reviewed in detail in 
Kretzschmar and Watt, 2012. Such approach consists of introducing the sequence of a 
recombinase (i. e.  Cre or Flp) into the locus of a gene of interest, in our case Cre or Flp 
would be knocked in the LHX6 locus. In parallel, a safe harbour is modified by using a 
targeting vector with the sequence of a constitutive and strong promoter driving the 
expression of a fluorescent protein. The expression of the fluorescent protein is 
prevented by placing a stop codon between the promoter and the fluorescent protein 
and the stop codon is flanked by Frt or LoxP sites, which promote site-specific 
recombination. Thus, when LHX6 is expressed, Flp or Cre recombinase will remove the 
stop codon to allow the expression of the fluorescent protein. As the fluorescent protein 
will be driven by a constitutive promoter it is expected that, all cells that once expressed 
the gene of interest, even transiently during development, will express the fluorescent 
protein with strong intensity throughout their life (Kretzschmar and Watt, 2012).  The 
71 
 
development of a second generation LHX6-mCherry reporter hold promise as a powerful 
tool, which can be visually detected under the microscope or high throughput screening 
platforms to functionally testing and identifying unknown determinants of cortical 
interneurons.  
Regarding the functional evaluation of the PV-GFP reporter, it was shown that after 65 
days of in vitro differentiation, my cultures contained SST+ and CR+ interneurons, but no 
PV+ interneurons were obtained, which limited the functional evaluation of PV-gfp 
reporter. The reasons behind the extremely low yield of PV+ interneurons are not clear, 
however it is unlikely to be due to a poor MGE specification, as the original protocol 
reported by Maroof et al, 2013; using a NKX2.1-GFP reporter line around 60% of cells 
became GFP+. In this report cultures were exposed to SHH and purmorphamine in a 
similar temporal window than in our modified protocol. Indeed, our modified protocol 
yielded 88.26±2.80 % of NKX2.1+ cells in my experiments. Additionally, using the same 
protocol another member of our lab found 72.3 ± 3.5% of NKX2.1+ cells and detected 
1.5 ± 0.9% of PV+ cells at day 60 of differentiation (Noakes et al., 2019). These results 
suggest that the initial MGE specification of our cultures is not compromised neither by 
the combination of patterning factors or by the temporal window in which those factors 
were applied. Moreover, Noakes’ findings showed that MGE-like progenitors obtained 
with our modified protocol could differentiate as PV+ cells.  
 A noticeable difference between our modified protocol and Maroof’s protocol is the co-
culture of MGE progenitors onto mouse embryonic cortical cells (E13.5) to promote 
maturation of interneurons. Under such conditions 5% of NKX2.1+ cells became PV+.  The 
generation of PV+ neurons obtained by Maroof supports increasing evidence that early 
neuron activity might act as either a permissive or an instructive cue to guide cortical 
interneuron maturation and survival, as  extensively reviewed in (Lim et al., 2018; 
Wamsley and Fishell, 2017).  This evidence might partially explain the practically null 
yield of PV+ interneurons in my cultures, since no neuron activity was promoted. In 
contrast to Maroof’s findings, Noakes et al., 2019 reported 1.5 ± 0.9% of PV+ cells 
without a co-culture step. However, in this study PV+ cells were detected in 3 out of 6 
experiments. This suggest that the generation of PV+ cells is not robust in our current 
differentiation paradigm and additional modifications are needed in order to overcome 
this limitation. The recent standardization of co-culture conditions in our laboratory 
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could be included into our differentiation paradigm, and may provide an alternative to 
assay the functionality of the PV-GFP reporter.   
Otherwise, the use of the CRISPR/Vp64dcas9Vp64 system to promote transcriptional 
activation of a target gene (Colasante et al., 2015; Vierbuchen et al., 2010) is another 
promising strategy that might allow us to evaluate the PV-GFP functionality. The 
CRISPR/Vp64dcas9Vp64 system is based on the same principle as CRISPR/Cas9 but 
unlike it, a genetically modified Cas9 is used, this Cas9 has an inactive nuclease domain, 
referred as dCas9 (dead Cas9). This modified dCas9 is also fused to two trans-activator 
domains (named Vp64dcas9Vp64). Thus, gRNAs can be designed to direct the 
Vp64dcas9Vp64 to the promoter of a gene of interest, where instead of promoting a 
double strand break, it will promote the transcription of the target gene. Through this 
strategy, gRNAs can be designed not only to evaluate the functionality of the PV-GFP 
reporter by targeting the PV promoter, but also to interrogate the role of specific 
candidate genes on different phases of interneuron development. 
Despite the accumulated knowledge about MGE development in mouse, the existence 
of some differences between mouse and human forebrain development have also been 
documented. For instance, a transient FOXA2+ population is found during in vitro 
differentiation of hPSCs as well as in human embryos, whereas a FOXA2+ population was 
not found in the developing ventral forebrain in mice (Maroof et al., 2013). In addition, 
although LHX6 expression is found in GABAergic cells into the monkey cortex, it is also 
reported some differences in the expression or combination of expression patters of LIM 
proteins (Such as LHX6) between mouse and primates (Abellan et al., 2010). The 
differences between mouse, primates and human forebrain development, highlight the 
relevance of studying human-specific mechanisms orchestrating the development of 
cortical interneurons. Our current and future experiments, using the LHX6-mCherry cell 
line, will provide insights on human-specific developmental mechanisms of cortical 
interneurons, such knowledge will be highly valuable to optimise differentiation 
protocols to obtain clinically-relevant populations of interneurons as PV and SST 
subtypes, as well as to study interneuron differentiation mechanisms in health and in 
disease.   
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5. The role of TGFβ signalling on cell cycle length regulation during the 
differentiation of MGE-like progenitors  
 
 
5.1 Introduction 
Gaining a deep understanding of how the intrinsic and extrinsic signals work in concert 
to govern cortical interneuron development is an area of intense research and will 
facilitate the development of improved strategies for in vitro generation of defined 
interneuron subtypes, which in turn provide a powerful model for studying molecular 
mechanisms of human diseases and drug screening. Following the generation of the 
LHX6 interneuron reporter line, the next aim of my thesis is to functionally testing 
potential modulators of MGE differentiation.  
In this chapter, I investigated the effects of the modulation of TGFβ signalling during in 
vitro MGE differentiation. TGFβ signalling was investigated due to previous reports 
suggesting it as feasible regulator of MGE differentiation. The first report came up in 
2010 by Maira and co-workers, who through a microarray analysis, found expression of 
members of TGFβ superfamily in the developing  mouse subpallium at E15.5 (Maira et 
al., 2010). Expression of TGFβ and BMP family members were detected at RNA level. 
Additionally activation of Smad2 (effector of the TGFβ branch) through phosphorylation 
at serines 465 and 467, was detected by immunocytochemistry at E12.5 and E15.5. 
Interestingly, phosphorylated smad2 (pSmad2) was found to be co-expressed and 
interacting with Dlx2. This transcription factor, together with Dlx1, have been related to 
controlling the migration of cortical interneurons towards the cortex (Le et al., 2007).   
Furthermore, by chromatin immunoprecipitation experiments, Dlx2, Smad1, Smad2/3 
and Smad4 were found localised at the enhancers of Dlx1/2, Dlx5/6 and Arx in the 
developing telencephalon at E15.5, suggesting a role for Dlx2/pSmad2 as transcriptional 
regulators of those genes.  Indeed, transient co-expression of Smad2 and DLX5 in COS 
cells led to an increased transcriptional activation of a lacZ reporter   driven by the Dlx5/6 
intergenic enhancer (Maira et al., 2010), further supporting a role for Smad2/Dlx-
proteins on the transcriptional control of genes related to MGE development.  
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Moreover, TGFβ signalling inhibition using a dominant negative form of Smad4 showed 
a role for TGFβ signalling in controlling the migration of sub-pallial cells towards the 
cortex in E12.5 forebrain explants. Considering that pSmad2 interacts with Dlx2, a 
discovery of the effects of TGFβ signalling on interneuron migration is in line with the 
previous identified role for Dlx1/2 on cortical interneuron migration (Le et al., 2007). 
Thus the work presented by Maira et al., provided the first evidence that functional 
interaction between TGFβ signalling and Dlx play a role in the development of 
telencephalic GABAergic neurons.  
A second report came up in 2016 by Sandberg et al. who through a combination of 
genetic and genomic approaches proposed a mechanism by which Nkx2.1 controls the 
network of transcription factors orchestrating the development of the mouse MGE and 
its GABAergic derivatives. Briefly, using a conditional Nkx2.1 knockout mouse (Nkx2.1 
KO), Sandberg and co-workers characterized the epigenetic state of regulatory elements 
of dysregulated genes in the knockout. The epigenetic state of those dysregulated genes 
was compared with the epigenetic state in the wild type mice. They found that Nkx2.1 
acts mainly as a repressor in the MGE, whereas in combination with Lhx6, it mediates 
the epigenetic transition into a transcriptionally active chromatin at regulatory elements 
to promote gene expression in MGE derivatives.  
In the study above, Tgfβ3 was found to be downregulated at mRNA level in the Nkx2.1 
KO MGE. Furthermore, binding elements for Nkx.2.1 and Lhx6 were found in the 
putative enhancer of Tgfβ3. These results pointed to Tgfβ3 gene as a putative 
transcriptional target of Nkx2.1 and Lhx6, both known to be major players in the 
specification of the MGE and cortical interneurons.  In addition, the activity of Tgfβ3 
putative enhancer was validated in the developing MGE by generating a transgenic 
mouse driving the expression of lacZ under the control of the putative Tgfβ3 enhancer, 
as a result β-gal activity was found in the SVZ and MZ of the MGE at E12.5. Moreover, 
through a luciferase reporter assay, opposing transcriptional changes were detected 
when Nkx2.1 and/or Lhx6 motifs were mutated in the Tgfβ3 enhancer. These 
experiments confirmed the transcriptional regulation of Tgfβ3 by Lhx6 and Nkx2.1. 
Considering the evidence of TGFβ signalling activation in the developing MGE, and the 
broad spectrum of its actions, I hypothesized that TGFβ signalling might participate in 
other aspects of MGE and interneuron differentiation. In this chapter, employing the 
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LHX6-mCherry reporter along with activation and pharmacological inhibition of TGFβ 
signalling respectively, I asked the next questions: 1) Does TGFβ signalling affects 
interneuron production?; if so 2)which are the cellular mechanisms by which TGFβ exert 
its effects during the differentiation of human MGE-like derivatives? 
 
 
5.2 Results 
5.2.1  TGFβ signalling  inhibition leads to a decreased production of LHX6-
mCherry+ cells 
In order to directly test a role for TGFβ signalling in MGE development and interneuron 
differentiation, I inhibited TGFβ signalling during the patterning stage of our 
differentiation paradigm using the small molecule inhibitor LY2109761, a dual kinase 
TβRI/II inhibitor which leads to a decrease of pSmad2 levels (Melisi et al., 2008).  
I firstly tested the temporal window by which TGβ inhibition affects interneuron 
differentiation by applying the LY2109761 inhibitor (referred to as LY hereafter) from 
differentiation day 11 to 20 (named condition 2 or C2) or day 16 to 20 (condition 3 or 
C3), fully covering the patterning stage (day 11 to 20) by SHH and purmorphamine. In 
the control conditions (condition 1 or C1), the vehicle DMSO was added instead of the 
inhibitor in the same time windows (Figure 5.1A).  After LY treatment, the differentiation 
continued as normally, and cultures were analysed by immunocytochemistry at day 21 
and flow cytometry at day 25, 35 and 45.  
Immunocytochemistry at differentiation day 21 was performed to detect markers 
related to telencephalic identity such as FOXG1, and MGE-fate (NKX2.1 and OLIG2). 
Positive cells for each marker were counted followed by statistical analysis. This analysis 
revealed that only OLIG2+ proportion was affected in the C2 (LY 11-20) treated cultures 
(C1: 19. 02 ± 5.12 %, C2: 4.35 ± 1.42 %); while NKX2.1 (C1: 94.08 ± 1.0%, C2: 89.15 ± 
2.91%) and FOXG1 (C1: 92.06 ± 2.27 %, C2: 89.49 ± 2.5 %) were not significantly affected 
(Figure 5.1B).   
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Counting and statistical analysis of the proportion of MGE markers in the cultures 
differentiated through condition C3 did not display any significant change: NKX2.1 (C1: 
91.31 ± 1.24 %, C3: 85.81 ± 2.12 %), FOXG1 (C1: 87.88 ± 3.44 %, C3: 87.29 ± 3.53 %), 
OLIG2 (C1: 4.51 ± 0.86 %, C3: 3.91± 0.87%). These results were also the case for the H7 
parental line, as in both cell lines, only the proportion of OLIG2+ cells was decreased  in 
the C2 (H7 C1: 21.76 ± 3.28 %, C2: 6.84 ± 1.95 %), while  no changes were detected in 
the proportion of positive cells for other makers treated with LY compared with cultures 
treated with the vehicle (Figure 5.2D). 
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Figure 5.1| TGFβ inhibition leads to a decrease of OLIG2+ cells in LHX6-mCherry reporter. A) 
Graphic description of the differentiation conditions to assay TGFβ inhibition effects. C1 control 
condition following the standard differentiation paradigm, the vehicle DMSO was added during 
the patterning stage. C2 in addition to the standard differentiation LY was added from days 11-
20. C3 additionally to standard differentiation LY was added from day 16-20. B) Staining for 
detecting MGE markers in cultures under the above differentiation conditions. C-E) 
Quantification of the proportion of positive cells for MGE markers in cultures in control C1 and  
C2 LY 11-20 condition. Data is presented as the median percentage with the 1st and 3rd quartiles 
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from 3 independent experiments. NKX2.1: C1 n= 8, C2 n=10, no significant difference P>0.05, 
two tailed t-test equal variances assumed; FOXG1: C1 n= 8, C2 n=10, no significant difference 
P>0.05, two tailed t-test, equal variances assume; OLIG2: C1 n=9, C2 n=10, ** P<0.01 compared 
by the Mann Whitney U test for independent samples. F-H) Quantification of positive cells for 
MGE markers in LY 16-20 condition. Data is presented as the median percentage  with the 1st 
and 3rd quartiles from 3 independent experiments. NKX2.1: C1 n= 6, C2 n=7, no significant 
difference P>0.05, two tailed t-test; FOXG1: C1 n= 6, C2 n=6, no significant difference P>0.05, 
two tailed t-test, OLIG2: C1 n=6, C2 n=7. No significant  difference P>0.05, two- tailed t test. 
Equal variances assumed. B scale bar 250 µm.  
 
 
Figure 5.2| TGFβ inhibition leads to a decrease of OLIG2+ cells in H7 line A) Staining for detecting 
MGE markers in cultures under the differentiation conditions in Figure 5.1A. B-D) Quantification 
of the proportion of positive cells for MGE markers in cultures in LY 11-20 condition. Data is 
presented as the median percentage with the 1st and 3rd quartiles from 3 independent 
experiments. NKX2.1: C1 n= 9, C2 n=9, no significant difference P>0.05, two tailed t-test equal 
variances assumed; FOXG1: C1 n= 9, C2 n=9, no significant difference P>0.05, two tailed t-test, 
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equal variances assume; OLIG2: C1 n=9, C2 n=9, *** P=0.001 two- tailed t test. Equal variances 
assumed for the three markers. E-G) Quantification of positive cells for MGE markers in LY 16-
20 condition. Data is presented as the median percentage with the 1st and 3rd quartiles from 3 
independent experiments. NKX2.1: C1 n=7, C2 n=7, no significant difference P>0.05, two tailed 
t-test equal variances assumed; FOXG1: C1 n=7, C2 n=7, no significant difference P>0.05, two 
tailed t-test, equal variances assume; OLIG2: C1 n=7, C2 n=7, no significant P>0.05, two- tailed t 
test. Equal variances assumed for NKX2.1 and OLIG2. Not equal variances assumed for FOXG1. 
A scale bar 250 µm. C1 control condition following the standard differentiation paradigm, the 
vehicle DMSO was added during the patterning stage. C2 in addition to the standard 
differentiation LY was added from days 11-20. C3 additionally to standard differentiation LY was 
added from day 16-20. 
 
 
To address whether the TGFβ inhibition affects further differentiation stages, 
progenitors differentiated through conditions above described were dissociated as 
single cells and analysed by flow cytometry at day 35 (around mCherry+ cells peak). 
Significant reductions in the proportion of mCherry+ cells were found in both inhibition 
conditions (Figure 5.3A). However, statistical analysis revealed a more severe reduction 
in condition LY 11-20, thus considering these results along with the decrease of OLIG2+ 
cells, subsequent experiments were performed on this condition.  
I then investigated the effects of  LY 11-20 treatment on the kinetic of mCherry+ cells 
during 60 days of differentiation by flow cytometry with the first analysis point at day 
25 (Figure 5.3B). There was no evident difference on the proportion of mCherry+ cells at 
day 25 between the LY treated and control cultures (Control 7.1 ± 0.23 %, LY 7.58 ± 0.40 
%). However, the proportion of mCherry+ cells became different as differentiation 
progressed leading to a maximum of 45% reduction in cultures treated with LY  fold 
change reduction in cultures treated with LY at day 45 (control 44.72 ± 1.06 %, LY 24.62 
± 1.11 % ). This difference was almost unchanged at day 60 in LY condition (Control 20.33 
± 1.24, LY 11.23 ± 0.72, 44.76% reduction). 
 Next, I investigated whether the observed reduction of mCherry+ cells translates to a 
decrease in GABAergic interneuron subtypes. Immunocytochemistry was performed on 
cultures fixed at day 65 of differentiation. The vast majority of the cells were GAD67+ 
indicating their GABAergic identity (Figure 5.3C), SST+ neurons were found in cultures 
under both differentiation conditions (Figure 5.3 C), whereas no PV+ cells were detected 
(Figure 5.3D left panel).  
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Since NKX2.1+ population gives rise to LHX6+ cells (committed to become GABAergic 
interneurons) and LHX8+ cells (committed to become cholinergic interneurons) (Lopes 
et al., 2012; Sussel et al., 1999), I wondered whether the decrease in the percentage of 
mCherry+ cells at day 60 was due to a shift on the differentiation potential of the MGE-
like cultures. I  therefore performed an immunocytochemistry to detect ChAT (choline 
acetyltransferase), the enzyme that catalyses the synthesis of acetylcholine in 
cholinergic neurons (Oda, 1999), which are also derived in the MGE from NKX2.1+ cells 
(Fragkouli et al., 2009; Sussel et al., 1999). I did not detect any ChAT+ neurons in cultures 
from both differentiation conditions (Figure 5.3D right panel).   
Quantification of SST stained cultures from 3 independent differentiations revealed 
that, although there was a decrease in the proportion of SST+ neurons in the LY 11-20 
condition, this reduction was not statistically different (two tailed t test). I also 
determined the generation of CR+ neurons, which is the other major subtype of 
interneurons in the cultures, no significant difference was found (two tailed t test). 
These results is somewhat surprising, given that LHX6 is post-mitotically expressed,  I 
hypothesised that MGE-like cultures treated with LY are maintained in the progenitor 
state for longer, thus when LY-treated progenitors finally proceed to the mitotic state 
they give rise to a similar number of SST+ neurons  to the control cultures.  
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Figure 5.3| TGFβ inhibition decreases mCherry+ cells but does not affect differentiation 
potential. A) Graph comparing the proportion of mCherry+ cells at day 35. Data presented as 
mean percentage ± SEM from 2 independent experiments. C1 (11-20) n=6, C2 n=6, C1 (16-20) 
n=6, C3 n=6, ns (no significant difference) P>0.05, ** P<0.01, *** P<0.001; one way ANOVA with 
post-hoc Tukey.  B) mCherry+ cells proportion is decreased in LY treated cultures along 60 days 
of differentiation. Data shows mean percentage ± SEM from 2 independent experiments (C1: 
n=6, C2: n=6). E) Representative immunostaining of interneuron markers at day differentiation 
day 65. D) Representative images of PV and ChAT immunocytochemistry. E) Quantification of 
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SST+ cells. Data is presented as mean  percentage ± SEM from 3 independent experiments (C1: 
n=23, C2: n=24). No significant difference was found P>0.05 two- tailed t test. Equal variances 
assumed. F) Quantification of CR+ cells. Data is presented as mean percentage ± SEM from 3 
independent experiments (C1: n=14, C2: n=15). No significant difference was found P>0.05 two- 
tailed t test. Equal variances assumed. C and D scale bar 250 µm. C1 control condition following 
the standard differentiation paradigm, the vehicle DMSO was added during the patterning stage. 
C2 in addition to the standard differentiation LY was added from days 11-20. C3 additionally to 
standard differentiation LY was added from day 16-20. 
 
 
 
5.2.2 TGFβ signalling blockade delays differentiation of MGE-like 
progenitors 
To test the above hypothesis, I firstly investigated whether LY treatment affects EdU 
incorporation of NKX2.1+ cells, as an indication of proliferative capacity.  At day 22, I 
administrated an EdU pulse for 2 hours to cultures in the LY 11-20 and control 
conditions, followed by double immunostaining to detect NKX2.1 and EdU (Figure 5.4A).  
I found that cultures treated with LY contained a higher proportion of NKX2.1+ cells that 
incorporated EdU than those in the control conditions (Figure 5.4B). 
To gain further support of the above findings, I performed RT-PCR analysis on genes 
whose expression has been associated to either proliferating progenitors (TOP2A and 
FABP7) or post-mitotic cells (STMN2, GAD1, SOX6 and LHX6) in the mouse MGE (Mi et 
al., 2018). These genes were reported to be highly expressed by the MGE cells as 
determined by single cell RNA-seq.  Samples from LY 11-20 and control cultures were 
collected at the pluripotent state (day 0) and at differentiation days 20, 30, 35 40, 45, 
50, 55 and 60.   
I found that MGE progenitor associated gene transcripts were detected at higher levels 
in the LY treated cultures from day 30 onwards compared to the control cultures; and 
their expression sustained higher at later time points than in control conditions (Figure 
5.4C).  
Conversely, genes expressed in post-mitotic MGE-derivatives such as LHX6 , SOX6 and 
GAD1, were detected at a higher level in control than in LY-treated cultures during day 
30-45, although the increase of STMN2 transcript in LY treated cultures was not 
consistent across all time points analysed (Figure 5.4D). A similar trend of LY-mediated 
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gene expression changes was also found for H7 cells differentiated under control and LY 
11-20 conditions (Figure 5.5). 
 
Figure 5.4| TGFβ inhibition promotes the maintenance of MGE-like cells as progenitors in LHX6-
mCherry reporter. A) Representative immunostaining for detecting NKX2.1+ cells incorporating 
EdU. Scale bar 250 µ. B) Proportion of NKX2.1+_EdU+ in control and LY treated cultures.   Data 
presented as mean percentage ± SEM from 2 independent experiments (C1: n=6, C2: n=6). ** 
P<0.01, two tailed t-test. Equal variances assumed. C) Expression profile of MGE-progenitors 
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associated genes TOP2 and FABP7 in control (blue) and LY-treated cultures (orange). Data is 
presented as the mean fold change ± SEM from two independent experiments. (DMSO: n=2, LY: 
n=2, at each time point).  D) Expression profile of genes associated to post-mitotic MGE 
derivatives in control (blue) and LY-treated cultures (orange). ). Data is presented as the mean 
fold change ± SEM from two independent experiments. (DMSO: n=2, LY: n=2, at each time point). 
C1 control condition following the standard differentiation paradigm, the vehicle DMSO was 
added during the patterning stage. C2 in addition to the standard differentiation LY was added 
from days 11-20.  
 
 
 
 
Figure 5.5| TGFβ inhibition promotes the maintenance of MGE-like cells as progenitors in H7 
line. A) Expression profile of MGE-progenitors associated genes TOP2 and FABP7 in control 
(blue) and LY-treated cultures (orange) Data is presented as the mean fold change ± SEM from 
two independent experiments. (DMSO: n=2, LY: n=2, at each time point). B) Expression profile 
of genes associated to post-mitotic MGE derivatives in control (blue) and LY-treated cultures 
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(orange). Data is presented as the mean fold change ± SEM from two independent experiments. 
(DMSO: n=2, LY: n=2, at each time point). Control condition following the standard 
differentiation paradigm, the vehicle DMSO was added during the patterning stage. LY: in 
addition to the standard differentiation LY was added from days 11-20.  
 
 
 
Interestingly, for most of the analysed genes their expression levels became similar in 
control and LY treated conditions by day 60 of differentiation. These results support the 
hypothesis that cultures treated with LY are retained in the progenitor state, resulting 
in a protracted terminal differentiation, hence a decrease in the proportion of post-
mitotic LHX6+ cells.  However, LY mediated action cease eventually, allowing LY-treated 
cells to proceed towards terminal differentiation.  
 
 
5.2.3 Inhibition of TGFβ signalling lengthened the cell cycle of MGE-like 
progenitors 
It is intriguing why the proportion of NKX2.1+ cells was not increased in the LY treated 
condition, despite an increase in EdU incorporation in these cells. Moreover, a 
hypothetic increase of NKX2.1+ cells would eventually lead to an increase of LHX6+ cells 
which subsequently would give rise to a higher proportion of SST+ cells, none of the 
results support this scenario.  
One potential mechanism that attribute to the seeming contradictive findings is a 
reduced proliferation rate due to changes in cell cycle. I therefore investigated TGFβ 
signalling inhibition leads to a lengthening of the cell cycle in MGE-like progenitors. A 
cumulative EdU study was performed in control and LY 11-20 conditions. The principle 
of this assay is originally described by Nowakowski et al., 1989 , and since it has been 
used in other studies to determine cell cycle length of neural progenitors (Arai et al., 
2011; Estivill-Torrus et al., 2002).  
Briefly, this method considers that the proliferative population, named growth fraction 
(GF) is asynchronously distributed along the cell cycle and is growing in a steady state, 
hence the number of cells in each phase is proportional to the length of that phase. 
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Therefore, giving pulses of a DNA –intercalating agent for increasing periods of time- will 
eventually mark all the proliferating cells in the culture. The proportion of labelled cells 
increases linearly along time   and can be applied to obtain the time of cell cycle (tc) and 
the time of  S-phase (ts) (the correlation referred to as the Nowakowski equation) 
(Figure 5.6C)  (Nowakowski et al., 1989). 
MGE-like cells were exposed to EdU for increasing periods of time up to 24 hours, 
followed by immunostaining for detecting NKX2.1 and EdU. To distinguish potential 
differential cell cycle length changes in  NKX2.1+ and NKX2.1- cell populations, I counted 
EdU+ cells in both populations (EdU+/NKX2.1+ and EdU+/NKX2.1-) at each time point. 
These proportions were plotted against time to obtain the equation describing the linear 
correlation between time and proportion of EdU+ labelled cells for each population 
(Figure 5.6 A, B). The slope and intersection values were employed to calculate the time 
of cell cycle and time in S-phase, following the model equation presented in Figure 5.6C.  
I found that LY treatment did not affect the Tc or Ts of the NKX2.1- cell population. 
However, LY exposure did resulted in a longer cell cycle (45.35 h) in NKX2.1+ cells than 
those in control conditions (39.61 h). LY-induced increase in the cell cycle length in 
NKX2.1+ cells was concomitant with the increase in the length of S phase, which 
lengthened from 16.14 h in control conditions to 21.37 h in LY treatment. No cell cycle 
lengthening was found in NKX2.1- cells between control and LY treated cultures (45.81h 
in both cases).  
These results suggest that a lengthening of the cell cycle, caused by temporal inhibition 
of TGFβ signalling, prolongs the progenitor stage of MGE- like cells in a time window 
prior to day 60, leading to a decrease in the proportion of mCherry+ cells. However, 
these NKX2.1+ cells retain their differentiation potential and were able to progress 
towards post-mitotic neurons once the LY effect faded. 
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Figure 5.6| TGFβ inhibition lengthened cell cycle of NKX2.1+ population.  A) Graphs of EdU 
incorporation along time for NKX2.1+ population. Data is presented as the percentage of double 
positive cells NKX2.1+_Edu+ out the total NKX2.1+ population ± SEM, n=6 at any time-point. B) 
Graphs of EdU incorporation along time for NKX2.1-   population. Data is presented as the 
percentage of double positive cells NKX2.1-_Edu+ out the total NKX2.1- population ± SEM, n=6 at 
any time-point. C) Graphical description of the Nowakowski equation. D) Table sumarising the 
tc and ts for NKX2.1+ and NKX2.1- population after DMSO and LY treatment. C1 control condition 
following the standard differentiation paradigm, vehicle DMSO was added during the patterning 
stage. C2 in addition to the standard differentiation LY was added from days 11-20.  
 
 
Length of Edu pulse 
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5.2.4 Cell cycle inhibitors accelerates the progression to post-mitotic state 
and  recovers the proportion of mCherry+ cells upon TGFβ inhibition 
I then investigated whether a forced cell cycle exit could accelerate neuronal 
differentiation and hence recover the proportion of mCherry+ cells in LY treated 
cultures. With this purpose, I followed the kinetic of mCherry+ population in control and 
LY- treated cultures. From day 35, around the peak time of mChery+ cell production, I 
added a combination of two cell cycle inhibitors (CCI), 10 µM DAPT (a γ-secretase 
inhibitor) and 2 µM PD0332991 (a CDK4/6 inhibitor) (Telezhkin et al., 2016). 
In contrast to previous experiments (Figure 5.3B) and control conditions without adding 
CCI (Figure 5.7A), forced exit of the cell cycle gradually recovers the proportion of 
mCherry+ population after TGFβ inhibition, at day 60 the proportion of mCherry+ cells 
was virtually equal to those in the control conditions (Figure 5.7B). By day 65 both 
conditions gave rise to similar proportion of SST+ and CR+ neurons (Figure 5.7 C-B). These 
results provide further support that the forced exit of the cell cycle accelerates the 
progression towards the post-mitotic state of MGE-like cells, in cultures previously 
retained as progenitors upon the inhibition of TGFβ. 
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Figure 5.7| Forced exit of cell cycle recovers mCherry+ cells proportion.  A)  Control kinetic of 
mCherry+ population in control and LY-treated cultures without cell cycle inhibitors. Data was 
obtained by flow cytometry and presented as the mean percentage ± SEM,  C1: n=3 at any time-
point, C1: n=3 at any time-point.  B) Kinetic of mCherry+ population upon the addition of cell 
cycle inhibitors in control and LY-treated cultures. . Data was obtained by flow cytometry and 
presented as the mean percentage ± SEM,  C1: n=3 at any time-point, C1: n=3 at any time-point. 
C) Representative immunostaining for SST, CR and GAD67 in cultures treated with cell cycle 
inhibitors. Scale bar 250 µ. D) Quantification of SST+ cells in control and LY-treated cultures upon 
cell cycle inhibitor addition. Data is presented as mean percentage ± SEM from 2 independent 
experiments, C1: n=6, C2: n=10.  No significant difference was found P>0.05 two- tailed t test. 
Non equal variances assumed. E) Quantification of CR+ cells in control and LY-treated cultures 
upon cell cycle inhibitor addition. Data is presented as mean percentage ± SEM from 2 
independent experiments, C1: n=6, C2: n=10.  No significant difference was found P>0.05 two- 
tailed t test. Equal variances assumed. C1 control condition following the standard 
differentiation paradigm, the vehicle DMSO was added during the patterning stage. C2 in 
addition to the standard differentiation LY was added from days 11-20.  
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5.2.5 TGFβ3 promotes the generation  of mCherry+ cells 
I then asked whether addition of TGFβ3 during MGE differentiation would elicit the 
opposite effect as observed on TGFβ signalling inhibition. TGFβ3 was added at day 14 to 
20 (Condition 2 or C2) during interneuron differentiation and compared to standard 
differentiation (Condition 1 or C1) (Figure 5.8A). Immunocytochemical analysis of pan-
forebrain (FOXG1 C1: 92.71 ± 2.17 %, C2: 94.06 ± 1.06 %) and MGE progenitor markers 
NKX2.1 (C1: 93.23 ± 1.56 %, C2: 94.28 ± 2.11%) and OLIG2 (C1: 49.11 ± 4.63%, C2: 48.73 
± 4.15%) on day 21 revealed no significant difference on the proportion of any of these 
populations, suggesting that the acquisition of MGE fate was not affected by the 
addition of TGFβ3 (Figure 5.8B-E). 
I next analysed, by flow cytometry the proportion of mCherry+ cells in control and 
TGFβ3-treated cultures at days 25, 35 and 45. I found that TGFβ3-treated cultures had a 
trend to contain a higher proportion of mCherry+, however, statistical significant 
increase was only found at day 25 (Figure 5.8F). Further differentiation of TGFβ3 and 
control cultures, gave rise to similar percentages of SST+ and CR+ neurons (Figure 5.8G-
I).  
Overall, these results seem to support and complement the findings caused by the 
inhibition of TGFβ signalling, as an opposite change on the proportion of mCherry+ 
population was found by adding TGFβ3. This result indicates that TGFβ signalling might 
regulate the progression from progenitor to post-mitotic state of MGE-like cells by 
modulating the cell cycle length. Since mCherry signal reports the expression of LHX6, a 
transcription factor whose expression is associated to post-mitotic cells in the MGE, 
therefore, changes in the proportion of mCherry+ and time at which this changes 
happen, suggest a shift on the kinetic to which MGE-like progenitors exit the cell cycle. 
This transition to the post-mitotic state seems to depend on the levels of activity of TGFβ 
signalling.  
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Figure 5.8| TGFβ3 addition increases mCherry+ percentage at day 25. A) Diagram of the 
differentiation conditions used for TGFβ3 addition. B) Representative images of the 
immunostaining for detecting MGE markers. C) Quantification of the proportion of NKX2.1+ cells. 
Data is presented as the median percentage with the 1st and 3rd quartiles, from two independent 
experiments, C1: n=6, C2: n=6. No significant difference was found P>0.05 two- tailed t test.  
Equal variances assumed. D) Quantification of the proportion of FOXG1+ cells. Data is presented 
as the median percentage with the 1st and 3rd quartiles, from two independent experiments, C1: 
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n=6, C2: n=6. No significant difference was found P>0.05 two- tailed t test.   Not equal variances 
assumed. E) Quantification of the proportion of OLIG2+ cells. Data is presented as the median 
percentage with the 1st and 3rd quartiles, from two independent experiments, C1: n=6, C2: n=6. 
No significant difference was found P>0.05 two- tailed t test.   Equal variances assumed. F) Graph 
comparing the proportion of mCherry+ cells at days 25, 35, and 45. Data was obtained by flow 
cytometry and presented as mean percentage ± SEM from 3 independent experiments, C1: n=9, 
C2: n=9, except at day 45 C1: n=6, C2: n=9. Significant difference was found at day 25 P<0.05 
two- tailed t test. No significant difference P>0.05 was found at day 35 and 45.  G) Representative 
image of the immunocytochemistry for SST, CR and GAD67 in control and TGFβ3 conditions. H) 
Quantification of SST+ cells. Data is presented as mean percentage ± SEM from 2 independent 
experiments, C1: n=8, C2: n=11. No significant difference P>0.05 was found, two tailed t-test.  
Equal variances assumed. I) Quantification of CR+ cells. Data is presented as mean percentage ± 
SEM from 2 independent experiments, C1: n=6, C2: n=9. No significant difference P>0.05 was 
found, two tailed t-test.  Equal variances assumed. B, G) Scale bar 250 µ. C1 control condition 
following the standard differentiation paradigm. C2 in addition to the standard differentiation 
TGFβ3 was added from days 14-20.  
 
 
 
5.3 Discussion  
Since in our differentiation paradigm, the addition of SHH and purmorphamine activated 
NKX2.1 expression, which in turn would activate LHX6 expression, and it is predicted 
that by the combined action of these transcription factors TGFβ3 is transcriptionally 
regulated, in this chapter, I have studied the effects of TGFβ signalling inhibition on MGE 
differentiation of hPSCs. My findings suggest that TGFβ signalling plays a role on cell 
cycle regulation of NKX2.1 cells, affecting the progression these progenitors to post-
mitotic neurons. Inhibition of TGFβ signalling retains the MGE-like cells as progenitors 
by lengthening the cell cycle. Once they exit the cell cycle, MGE-like cells resumed their 
differentiation to LHX6+ cells that subsequently gave rise to SST+ neurons, indicating that 
TGFβ signalling inhibition during the patterning did not affect cell fate.  
A TGFβ signalling- dependent control in cell proliferation and cell cycle-exit has been 
previously demonstrated in other regions of the brain, such as the dorsal midbrain and 
the cortex (Falk et al., 2008; Seoane et al., 2004). In the cortex, TGFβ signalling induces 
a cytostatic effect by directly promoting transcriptional activation of the cyclin-
dependent kinase inhibitor p21, this activity is mediated by the action of Smad2/3 and 
FoxO, and leads to a cell cycle arrest at G1 (Seoane et al., 2004). While the inhibition of 
TGFβ signalling by ablation of Tβr2 lead to an increased proliferation and decreased cell-
cycle exit in the dorsal midbrain (Falk et al., 2008). 
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Consistent with the current, the above mentioned reports, activation of TGFβ pathway 
has been reported to induce the transcriptional activation of p21 and p27 while 
promoting cyclin D1 suppression, which together facilitate the exit of the cell cycle. In 
contrast, inhibition of TGFβ signalling blocks the activation of p21, and maintains neural 
progenitors in cell cycle (Garcia-Campmany and Marti, 2007; Seoane et al., 2004; 
Siegenthaler and Miller, 2005).  However, the effects of TGFβ signalling manipulation on 
cell cycle length varies among these studies. While activation of the signalling by Tgfβ1 
ligand caused the exit of the cell cycle without modifying its length (Siegenthaler and 
Miller, 2005),  the inhibition of TGFβ signalling by loss of function of Tβr2 triggered 
ectopic activation of Wnt1/β-catenin and Fgf8 which promoted increased proliferation, 
inhibition of cell cycle exit and shortening of the cell cycle (Falk et al., 2008). The 
different effects of TGFβ signalling manipulation on cell cycle length regulation by these 
and my studies might be explained by context-dependent mechanisms, which remain to 
be characterised. 
 Although my results show a clear trend towards the lengthening of the cell cycle (Figure 
5.6D), the cell cycle time obtained by my study may not be accurate. This is because that 
estimation of the cell cycle time depends on the precise determination of the growth 
fraction in the cell population of interest, which in turn depends on the plateau of the 
proportion of cells labelled with EdU (Nowakowski et al., 1989). However, a plateau of 
EdU+ was not reached in my experiment. The cell cycle length needs to be further 
validated by collecting cell samples with longer EdU pulse. 
The cumulative EdU labelling assay also allows the estimation of the S-phase length 
(Figure 5.6D). Interestingly, my results suggest that the increase in the S-phase duration 
(5.23 h lengthened) attributes to the overall lengthening of the cell cycle (5.74 h 
lengthened). A longer S-phase has been related to apical and basal cortical progenitors 
dividing to expand the progenitor pool compared to the progenitors undergoing 
neurogenic division (Arai et al., 2011; Spella et al., 2011). This finding supports that TGFβ 
signalling inhibition retains MGE-like cells in the progenitor identity, which is further 
supported by the fact that forcing the exit of the cell cycle gradually recovers the 
proportion of mCherry+ cells in cultures treated with LY (Figure 5.7 A and B). The exiting 
of the cell cycle was promoted by the combined effect of DAPT (a γ-secretase inhibitor) 
and PD0332991 (a CDK4/6 inhibitor) (Telezhkin et al., 2016), while the last specifically 
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targets cell cycle regulators, the effect of inhibiting NOTCH signalling by DAPT might be 
more complex. NOTCH inhibition enhances neuronal differentiation, however, the exit 
of the cell cycle is necessary to boost neuronal differentiation (Crawford and Roelink, 
2007; Telezhkin et al., 2016). This raises the question of whether such effect could affect 
the neuronal cell fate. While the answer to this interrogation would need to include in 
the comparisons the proportion of interneuron subtypes obtained after treating the 
cells only with PD0332991; it is unlikely that the initial specification of progenitors is 
changed in response to DAPT.  Since it has been shown that,   the in vitro differentiation 
of other caudally–derived ventral neuronal types (motoneurons and interneurons) were 
not affected with the inclusion of DAPT while Shh was also activated. Therefore, in 
absence of Notch signalling, the already Shh-induced neurons only acquired a more 
mature phenotype precociously (Crawford and Roelink, 2007).  
However, it has been also proposed that, during in vitro differentiation of cortical 
interneurons from  mESCs, the administration of DAPT  further enhances the generation 
of Sst+ interneurons at the expenses of Pv+, using culture conditions that were already 
biased to become Sst+ (Tischfield et al., 2017).  In contrast to the experiments from 
Tischfield and colleagues, the addition of DAPT and PD0332991 did not enhanced the 
derivation of  SST+ interneurons. Therefore, it is possible that the apparent increase of 
SST+ interneuros, seen by Tischfield, was an effect of the quicker acquisition of more 
mature phenotypes, which is also favoured by the fact that during development SST+ 
interneurons arisen before than PV+ interneurons (Mukhopadhyay et al., 2009). A more 
formal answer to this question might be provided by the study of interneuron 
development in a conditional notch mutant, where the effects of the downregulation of 
notch around the neurogenesis in the MGE can be tested.   
TGFβ3 at 1ng/ml was added to the cultures with the aim of testing whether the opposite 
outcomes to the inhibition could be promoted. A slight but significant effect was 
observed on the proportion of mCherry+ cells only at day 25. This effect could be 
increased by using higher concentration of TGFβ3, as some of the effects on cell cycle 
exit of another member of the TGFβ family, TGFβ1 were induced by using 40 ng/ml 
(Siegenthaler and Miller, 2005). Alternatively, the restricted increase of mCherry+ cells 
to day 25 could be simply due to this effect cannot last longer. The pronounced decrease 
of mCherry+ cells in the LY treatment contrasts with the slight increase with the addition 
95 
 
of TGFβ3. This might be related to the presence of FOXG1, which is broadly expressed 
in MGE-like cultures. FOXG1 has been reported to repress the action of Smad2/3 and 
FoxO complex to activate p21 (Seoane et al., 2004), this might interfere with the 
transduction of TGFβ signalling to exit the cell cycle meaning a small increase of 
mCherry+ cells. In contrast to the addition of TGFβ3, the presence of FOXG1 in the 
cultures might potentiate the effect of LY, leading to a strong inactivation of p21, 
therefore keeping cells in cell cycle with an evident decrease on the production of 
mCherry+ cells. With regard to interneuron subtype, no significant difference was found 
on the proportion of SST+ or CR+ neurons, indicating that addition of TGFβ did not bias 
the acquisition of the interneuron subtype fate.  
With caveats that one of the major interneuron subtypes were almost absent in my 
culture, my results indicate that TGFβ signalling is unlikely a major regulator of 
interneuron subtype fate specification. However, during interneuron development the 
exit of the cell cycle is not coupled to the beginning of SST or PV expression (Nicholas et 
al., 2013; Wamsley and Fishell, 2017). Indeed, this uncoupled process opens debate 
about the time at which the interneuron subtype fate is acquired. Two main hypothesis 
are in discussion. One proposing that subtype fate is determined soon after the exit of 
cell cycle whereas the second view suggests that the fate is stablished when the 
interneuron settle in its final position in the brain; where cues of the surrounding 
environment finally determine interneuron subtype (Hu et al., 2017b; Lim et al., 2018; 
Wamsley and Fishell, 2017)  
Due to the debate on the time at which interneuron subtype is acquired and the lack of 
PV+ in my cultures, it is not possible to rule out an effect on the interneuron fate 
specification as a consequence of TGFβ signalling modulation. Indeed it is very intriguing 
that independently on the proportion of LHX6+ cells obtained in each of the culture 
conditions used in this work, only a portion of the LHX6+ cells became SST+ neurons 
(ranging from 4.94 to 7.30 %.) Similar percentages were found in Noakes et al., 2019.   
These low percentages of SST+ and PV+ interneurons might be suggesting that relevant 
cues are lacking or not sufficient in the cultures to promote a more efficient terminal 
differentiation of the LHX6+ cells, which  have been conceived as  a proto- interneuron 
state (Flames and Marin, 2005). A more accurate answer to whether TGFβ signalling 
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regulates interneuron specification could be obtained by studying interneuron 
specification in a knockout mouse for TGFβ3 in the MGE.  
In summary, findings described in this chapter present evidence on the role of TGFβ 
signalling in regulating neurogenesis of hPSC-derived MGE-like cells by modulating cell 
cycle length. These findings are in line with the TGFβ3 expression pattern in the mouse 
MGE, where TGFβ3 is highly expressed in the subventricular zone and mantle zone of 
the MGE (Sandberg et al., 2016).  Further characterization of the cell cycle regulators 
implicated in the control of the cell cycle length of MGE-like cells is necessary to 
delineate the specific mechanisms through which TGFβ exert its effects on MGE-like 
progenitors.  
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6. General discussion  
 
6.1 Summary of findings 
In this thesis, I generated a hPSC reporter cell line for tracking hPSC-derived cortical 
interneurons. The key properties of pluripotency and differentiation potential to MGE-
like progenitors were validated. I provide evidence that the knock in mCherry faithfully 
labelled LHX6+ cells and that mCherry expression was maintained in the SST+ 
interneurons upon further differentiation in vitro. Moreover, mCherry expression 
recapitulated the expected temporal and spatial expression pattern of LHX6 during 
differentiation into different neuronal subtypes, demonstrating a restricted expression 
to the MGE-like lineage. Thus, my findings highlight the potential of this reporter line as 
a valuable experimental platform for identifying new determinants of interneuron fates. 
This cell line was designed as a dual reporter to also identify the PV+- interneuron 
subtype. However, the low efficiency to generate these interneurons (Nicholas et al., 
2013; Noakes et al., 2019; Sun et al., 2016) prevented the validation of PV-GFP reporter 
in the current study.  
Using the LHX6 reporter line, I investigated a role for TGFβ signalling in MGE/interneuron 
differentiation.  Pharmacological inhibition of TGFβ signalling prolonged the MGE 
progenitor stage by lengthening the cell cycle, with no effect on the production of CR+ 
and SST+ neurons. In contrast, addition of exogenous TGFβ3 resulted in an early 
production of mCherry+ cells, possibly due to a higher percentage of MGE-progenitors 
exited the cell cycle at earlier stages of differentiation. The results presented in Chapter 
5 suggest that TGFβ signalling controls the progression from progenitors to post-mitotic 
neurons in human MGE-like (NKX2.1+) cells through the modulation of the cell cycle 
length. 
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6.2  LHX6-mCherry reporter in the identification of new determinants of 
human MGE-derived interneurons 
In vitro differentiation of MGE-derived cortical interneurons begins with the induction 
of NKX2.1+ neural progenitors. These cells can be produced highly efficiently in this study 
and previously published works (Maroof et al., 2013; Nicholas et al., 2013; Noakes et al., 
2019). However, only a proportion of these NKX2.1+ progenitors seems to progress to 
LHX6+ immature interneurons in my culture. Furthermore, the yield of defined MGE 
derived interneuron subtypes (SST+ of PV+ ) remains low (Maroof et al., 2013; Nicholas 
et al., 2013; Noakes et al., 2019; Sun et al., 2016) or the phenotype might not be stable 
(Colasante et al., 2015). The lack of efficient interneuron differentiation protocol is due 
largely to our limited understanding on the control of interneuron diversity and subtype 
fate specification. This limitation is further complicated by the protracted acquisition of 
subtype identity both in mice (Mukhopadhyay et al., 2009), and during hPSC 
differentiation (Nicholas et al., 2013). 
Given the significance of PV and SST interneurons in neuropsychiatric and 
neurodegenerative diseases, it is important to develop better paradigms for generating 
these cells in vitro from hPSCs. The optimisation of a differentiation protocol could be 
achieved by using a high throughput-screening platform that allows the analysis of 
several potential determinants at the time. The implementation of this screening 
platform would need the use of a reporter that can be easily detected under the 
microscope. Since the LHX6-mCherry reporter has been shown to be functional and 
specific but mCherry signal is too low, then the design and derivation of a second 
generation reporter that can be directly visualised under the fluorescent microscope 
holds an enormous potential for the identification of new interneuron determinants. 
The strategies for deriving a second-generation reporter were discussed in section 4.3.  
With regard to potential determinants to be screened, valuable information has become 
available from recent publications exploiting the use of single-cell RNA-seq technology, 
and by integration of genetic and genomic data of the genes downstream of Nkx2.1. 
With respect to single cell RNA-seq studies, the first published data was done by Mayer 
et al., 2018, where the authors presented evidence of specification of SST+ and PV+ 
interneurons in post-mitotic cells within mouse developing MGE at E13.5. These sub-
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populations could be identified by the expression of a set of genes whose expression is 
conserved in adulthood.  Mef2c, Erbb4 and Plcxd3 were proposed as early marker genes 
for PV+ interneurons whilst Sst, Tspan7 and Satb1 would be early markers for SST+ 
neurons (Mayer et al., 2018).  In this study the role of Mef2c was further investigated. It 
was found that its conditional deletion caused specific loss of PV+ interneurons, 
highlighting this gene as a potential determinant of PV-fate.   
Another single cell RNA-seq study was published a few months later, also finding that 
PV or SST populations can be distinguished as early as E12.5. Mice-MGE cells were 
identified as an early PV+ population when expressing Ccnd2 and St18, while the early 
SST+ population was marked by the expression of Epha5, Cdk14 and Maf. To validate 
these results, the authors overexpressed Maf in the MGE, finding that SST+ population 
increased at the expenses of PV+ (Mi et al., 2018). 
Additionally, from the genetic and genomic data presented in Sandberg et al, 2016, a set 
of genes were identified as potential targets of Lhx6 and Nkx2.1. In this work,   a broad 
analysis of the function of Nkx2.1 was carried out to understand how this transcription 
factor controls gene networks to guide the development of MGE-derived interneurons. 
From the information derived from Sandberg’s work, I shortlisted possible genes with a 
role in MGE development following the next criteria.  First, I considered genes that the 
authors reported to be potential targets of Lhx6 and Nkx2.1. Next, I limited to genes 
whose expression has been documented in the developing MGE and finally, these genes 
shown to be downregulated in the conditional Nkx2.1 knockout mouse.  Based on these 
criteria, Tgfβ3, Etv1 and Sox6 were highlighted as relevant genes. Another candidate is 
Nhxp1, since it was described to be expressed in the mantle zone of the MGE at E13.5 
and its expression preserved in cortical interneurons (Sandberg et al., 2016).  In this 
thesis, I have begun the investigation of the role of TGFβ signalling in human MGE-like 
cells, however, it would be interesting to extend the investigation to SOX6, ETV1 and 
NXPH1.  
Even though the above genes have been independently shown to contribute to different 
developmental stages of cortical interneurons, their ability to instruct interneuron 
subtypes from hPSCs has not been assayed. For instance, it is known that Sox6 functions 
downstream of Lhx6 and its loss of function caused a decrease in the number of PV+ and 
SST+ interneurons, defects on interneurons position and maturation that led to an 
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epileptic phenotype at P15 (Azim et al., 2009; Batista-Brito et al., 2009). ETV1 has been 
reported not being required for specification or migration of PV interneurons, however 
seems to have a role on transcriptionally controlling the expression of Kv1.1 (a 
potassium channel voltage dependent), which lately impacts on the electrophysiological 
properties of PV interneurons (Dehorter et al., 2015). Less information is available about 
NXPH1 role in mammalian interneuron development. However, it is known that nxph1 
is expressed in the sub-pallium during zebrafish development and its expression is 
confined to interneurons. Interestingly, this gene was found to be downregulated in the 
mib (an E3 ubiquitin ligase) zebrafish mutant, which develops seizure activity (Thomas-
Jinu and Houart, 2013).  Furthermore, NXPH1 gene was found to be close to a 
duplication CNV identified in ASD families, consequently suggested as a potential gene 
of risk for autism (Salyakina et al., 2011).      
The above evidence shows involvement of these genes in the development and function 
of cortical interneurons. Nonetheless, any of these studies have tested whether their 
over-expression (alone or in combination) can elicit a determinant function of 
interneuron subtypes. Therefore, developing a system for overexpressing these genes 
in a second generation LHX6-mCherry reporter will help us to functionally evaluate their 
potential as determinants of cortical interneuron development.  
 
6.3 Mechanisms  and crosstalk of  TGFβ signalling in MGE neurogenesis  
A deeper analysis of TGFβ mechanisms in the MGE is needed in order to determine 
whether shared mechanisms converge to mediate its functions in different regions of 
the brain (Falk et al., 2008; Garcia-Campmany and Marti, 2007; Seoane et al., 2004; 
Siegenthaler and Miller, 2005). For instance, it is known that TGFβ signalling interacts 
with Wnt signalling in the dorsal-caudal midbrain in mouse to cooperate in the 
regulation of proliferation over neuronal differentiation. In this region the inhibition of 
TGFβ signalling by ablation of Tgfbr2 caused an ectopic expression of Wnt1 and 
increased β-catenin nuclear accumulation, which through its target Cyclin D1 promoted 
increased proliferation in neuroprogenitors (Falk et al., 2008). Interestingly WNT/β-
Catenin signalling has been recently shown to have a role on the maintenance of the 
MGE progenitors derived from hPSCs, where the activation of WNT signalling maintain 
human MGE-like progenitors in an undifferentiated state, while its ablation  led to an 
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early exit of the cell cycle and accelerated neurogenesis (Ma et al., 2019). Future studies 
should be directed to understand whether the effects, here reported for TGFβ signalling 
in the human MGE-like neurogenesis are linked to or dependent on WNT signalling. 
In addition to the identification of signalling pathways involved in the maintenance of 
human MGE-like progenitors, a key question that remains to be addressed is whether 
the manipulation of these signalling pathways influences the acquisition of the 
interneuron subtype fate.  From a plethora of studies concerning the development of 
MGE-derived cortical interneurons, it is known that there is a highly regulated 
temporality at which PV or SST interneurons are born. SST+ have a tendency to be born 
earlier than PV+ interneurons (Fertuzinhos et al., 2009; Mayer et al., 2018; Nicholas et 
al., 2013), hence, the time at which a progenitor exit the cell cycle might determine its 
competence to become a specific interneuron subtype.  
The investigation of a potential interaction between TGFβ and WNT signalling is 
especially relevant since it was recently reported that Wnt signalling participates on 
interneuron subtype specification in mice (McKenzie et al., 2019). In this report was 
shown that Wnt signalling shifts from the regulation of proliferation to specification, the 
later was mediated by non-canonical Wnt signalling via the activation of Ryk receptor. 
Interestingly, the canonical pathway was also activated (McKenzie et al., 2019). How 
these two parallel pathways are regulated and how they might interact with other 
signals to regulate proliferation, neurogenesis and specification, are questions to 
address for deciphering how these developmental processes are orchestrated during 
interneuron differentiation. The understanding of these mechanisms will open the 
possibility of manipulating these pathways to bias the interneuron subtype of MGE 
progenitors. 
In this thesis, I presented evidence that TGFβ signalling is implicated in the regulation of 
the progression from progenitors to pots-mitotic neurons in human MGE-like 
progenitors. This result, along with a previous report showing that the forced exit of the 
cell cycle of GABAergic progenitors accelerates neuron maturation at 
electrophysiological level (Telezhkin et al., 2016), raise the question of whether TGFβ 
signalling could promote cortical interneuron maturation. Indeed, Tgfβr1 mutant has 
been shown to decrease the number, migration and dendritic arborisation of new-born 
neurons in adult mouse hippocampus (He et al., 2014); therefore further 
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characterisation of the effects of TGFβ3 is needed to determine whether this signalling 
guides interneuron maturation.  
The findings reported here provide new contribution to our understanding on the 
control of neurogenesis of human MGE progenitors. This knowledge may be used to 
modulate the speed of human interneuron production in vitro.  
 
6.4 Conclusions  
In this thesis, I successfully generated a functional LHX6-mCherry reporter that could be 
used for studying the control of human MGE-derived interneuron development. Upon 
differentiation of the LHX6-mCherry hPSCs, mCherry signal recapitulated LHX6 
expression pattern and faithfully labels LHX6+ interneurons while showing lineage 
restriction. These characteristics allowed me to use the reporter to gain insights into the 
role of TGFβ signalling on MGE-like progenitor’s differentiation. I found that this 
signalling pathway participates in the decision of proliferation versus differentiation of 
MGE-like progenitors by regulating cell cycle length with no apparent effects on 
interneuron subtype fate. Ultimately, the reporter line generated in this thesis provides 
a tool as a screening platform to discover new factors involved in the acquisition of 
interneuron fate and interneuron-subtype specification. 
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